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Melt spheronization as a direct rotary shaping approach is a relatively new process. Very 
limited studies have been reported to provide insights to the process of developing spherical 
solid dispersion pellets prepared by hot melt extrusion. Moreover, the influences of 
spheronization conditions and the configuration of the spheronizer’s geometry on properties 
of melt pellets, such as shape in particular, are yet to be well understood.  Formulation 
composition and viscoelastic property of the melt materials are hypothesized to be the key 
attributes for the spheronization process and properties of the final products. Therefore, 
understanding the impact of spheronization process under different conditions coupled with 
variations in the viscoelastic properties of formulations may offer insights into the future 
development and manufacturing of solid dispersion pellets using hot melt extrusion. The 
research work has provided a better understanding of the spheronization process and the 
influence of the physicochemical properties of melt pellets containing filler excipients as 
extrusion and spheronization aids. In addition, shape and rheological attributes of pellets were 
investigated to provide a better understanding of the characteristics of the melt pellets.   
In this study, plasticization effects of a hydrophilic excipient as an extrusion aid, polyethylene 
glycol, on physicomechanical properties of pellets are systematically studied. In addition, the 
impact of process conditions such as extrusion temperature, spheronizer rotation speed and 
duration on spheronization were explored. The concentrations of plasticizer showed positive 
influences on pellets shape in terms of roundness and aspect ratio, however, it generated 
negative impacts on size, size distribution and effective yield when elevated mechanical 
forces were applied during spheronization.  
Similarly, incorporating of meltable drug, ibuprofen as unconventional plasticizing aid was 
further evaluated and the impact of the viscoelastic properties of melt extrudates on melt 
xiv 
 
spheronization process was investigated. It was noted that, in addition to the concentration of 
plasticizing agent, molecular weight also played an essential role for mechanical properties of 
hot melt extrudates. The comparable observations were seen in terms of physical properties 
such as mean particle size, Span, effective yield, pellets’ roundness and aspect ratio. 
Importance of rheological properties and glass transition temperature on processibility were 
also noteworthy.   
Additionally, spheronization disc geometries (pyramidal shaped studs in cross-hatch pattern 
and line grooves running radially from the center of the disc) on formulations containing 
water insoluble, microcrystalline cellulose, and soluble, hydroxypropyl cellulose, 
spheronization aids were evaluated.  Influences of physical properties such as particle sizes 
and molecular weights of spheronization aids were carefully studied. Physicochemical 
properties of the melt pellets were characterized to provide understanding on the impact of 
equipment configurations and process conditions. The results from the study established the 
interactions between process parameters and pellets properties. 
In conclusion, the results and findings from this study may enhance the understanding of the 
requirements for the development spherical solid dispersion pellets using the melt 
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1.1. Types of extrusion: Dry and wet extrusion 
 
Extrusion is an established technology that has been developed over the last century and 
applications of extrusion process are diverse, and in many industries. Extrusion is a process 
for producing a new material form (extrudate) by forcing a material through an orifice or die 
under controlled conditions (Ghebre-Selassie and Martin, 2003). The extrusion process has 
the ability to create products with different release rates using the same drug substance by 
manipulating the dosage form, to produce multiparticulates for immediate and modified 
release systems. The process also allows the production of multiparticulates of uniform size 
and narrow size distribution, with the ability to operate as a continuous process. Extrusion 
can be classified from the process perspective into two types; dry extrusion and wet 
extrusion. 
Dry extrusion, often also called as melt extrusion is a continuous process whereby the API 
and polymers, in general, are premixed with other excipients or individually fed into the 
extruder. Melt extrusion may be broadly classified into molten systems under temperature 
control or semisolid viscous systems. In molten extrusion, heat is applied to the material in 
order to control its viscosity, to enable good flow through the die. Semisolid systems are 
multiphase concentrated dispersions containing a high proportion of solid mixed with a liquid 
phase (Tadmor and Klein, 1970).  Melt extrusion is also frequently employed to disperse API 
in a given matrix down to the molecular level to enhance the mobility of original crystalline 
API. The use of melts for solid molecular dispersions such as glass or solid solutions is well 
studied. The important benefit of a melt process is its solvent-free formation of solid 
dispersions (Lefebvre et al., 1985). Moreover, the melt extrusion process is capable of 
handling active agents with different particle sizes,  amorphous solids or other polymorphic 
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forms, leading to the same product (Yano and Kleinebudde, 2010). It is the advancement of 
the technology that gives new hope to the glass or solid solution approach as a delivery 
system for solubility limiting APIs.  The physical mixture is processed at a defined thermal 
and mechanical condition as a continuous process to generate a final product of uniform size, 
shape and content. Theoretically, melt extrusion can be sub-divided into feeding, melting or 
softening, mixing and conveying and down-stream processing (Shah et al., 2013). Each of 
these steps can affect the properties of the final extrudates. Gravimetric (loss in weight) or 
volumetric feeders are generally used with pharmaceutical extruders. A volumetric feeder 
that operates by the principle of volume displacement by the use of a pump is most suited for 
pre-blends. Feeding to the screw extruder is commonly conducted in a “starve-fed” mode and 
with efficiently mixed feed material, using either gravimetric or volumetric feeders to 
dispense the material directly into screws, will prevent feed accumulation. Thus, the mass 
flow rate is independent of screw speed (Shah et al., 2013). The mass flow rate at the feed 
zone is equal to the mass exiting the barrel when the process is at a steady state under a 
starve-fed mode, and thus, accumulation in the barrel is negligible. Conversely, screw speed 
can have a significant influence on the residence time distribution of the feed material 
(Rauwendaal and Noriega, 2001). Properties of the final product are influenced by mixing 
efficiency in the barrel and it can be categorized as distributive mixing which contributes for 
content uniformity. Dispersive mixing may contribute to a situation where size reduction and 
distribution is experienced (Wilson et al., 2012). In pharmaceutical industry, several 
downstream solutions like shaping, sizing and milling can be adopted to develop the melt 
extrudates as single or multiple units oral dosage forms.  
Wet extrusion process can be considered as one of the wet granulation methods where dry 
powder blend is mixed with binding solution and the mixture is consolidated by mechanical 
agitating force during wet extrusion process. Wet extrusion process comprises serval unit 
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operations: blending, wet massing, extrusion, pelletizing or spheronization and drying. In the 
first step, the materials are mixed to achieve homogeneous powder blend and then wet 
massed by the addition of a liquid binder to produce a sufficiently plastic mass. The wet mass 
is next kneaded to a density approaching its saturation density by expelling entrapped air. 
During this wet massing step, evaporation of the binding liquid should be restricted to a 
minimum. Selection of granulator needs careful consideration to ensure that energy 
introduced for mixing should not be transformed into heat. Controlled dispersion of fluid and 
the amount of granulation fluid used are the critical parameters for optimizing the plasticity 
and cohesiveness of the properties of final extrudates. The second step of the process is the 
shaping of the wet mass into long rods by extrusion. The wetted mass is introduced into the 
extruder where it is continuously conveyed to form cylindrical rods of uniform size and shape 
by forcing through circular dies or multi-holed screens. Non-circular dies are available but 
rarely used for pharmaceutical extrudates.  The wet extrusion process is used not only in the 
pharmaceutical industry but also in the food, ceramics and polymer industries. Extrusions can 
be performed using four main classes of extruders, namely screw, sieve and basket, roll and 
ram extruders. The extrudates are then pelletized or spheronized to round off the wet 




1.2. Types of extruders for pharmaceutical applications 
 
Extruded materials are commonly seen in the polymer and food processing industries and an 
extruder, in general, operates like a continuous mixer which involves operations such as 
kneading, shearing, heating, melting and cooling.  Depending on modes of operation, 
continuous or discontinuous, classification of extruders can be generally defined as per Figure 
1 (Rauwendaal, 2014). Although many extruders shown in Figure 1 are common in industries 
such as polymer and food, ram and screw extruders are better known for pharmaceutical 
applications, in connection with preparing spheroids for the development of multiparticulate 
dosage forms. Ram extrusion uses high pressure to displace a ram to push the heated material 
through a die. The design of a ram extruder is simple and operates under a discontinuity 
mode. It works with the positive displacement ram which generates high pressure to force 
material through the die (Vynckier et al., 2014). Screw extruders which operate by 
transporting materials via screws and they are preferred over ram extruders since they provide 
shear forces with intense mixing, resulting in a better homogeneity and temperature 
uniformity. Single screw was first utilized in pharmaceutical industries as the use of twin-
screw extruders had not been well-developed till the 1940s. The single screw provides 
continuous conveyance and the feeding principle of a single screw extruder is by a flood 
feeding and the screw takes what it can from the filled hopper. This has an effect on 
processing in that any increase in screw speed therefore increases the output level (Ghebre-
Selassie and Martin, 2003). The advantages of twin screw, on the other hand, became more 
apparent after its introduction because of its superior functionality by allowing operations 
such as mixing, melting, granulation and compounding processes to be performed in a single 
equipment which improves manufacturing efficiency.  
Generally, twin screws or multiple screws extruders can be categorized into intermeshing and 
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non-intermeshing. The intermeshing extruder is self-wiping and it minimizes the non-motion 
appendages and prevents localized overheating of material in the extruder. The extruder 
functions by a first in / first out principle as the material does not rotate along with the screw. 
The non-intermeshing extruder is often used for processing when a large amount of volatile 
needs to be removed from the material by a large vent opening that can be accommodated as 
the screws are positioned apart from each other. These screws are also used when processing 
highly viscous materials, where the intermeshing extruder can be problematical with torque 
buildups.  The intermeshing twin screw extruders are further categorized as co-rotating (same 
direction) and counter-rotating (opposite direction), depending on the direction of rotation of 
the screw.  Co-rotating extruders are more commonly used for pharmaceutical applications, 
with the exception that sometimes, counter-rotating (non-intermeshing) types are employed 
when a small processing window is needed for heat sensitive materials (Shah et al., 2013). 
Since the co-rotating extruder provides intensive mixing and ensures almost complete 
emptying of the extruder, it minimizes the loss from a product which is important for an 
expensive drug. In addition, it operates by a first in, first out principle which prevents 
localized overheating of its content (Vynckier et al., 2014). The major differences between 
single screw and twin screw extruders are in their conveying or transport mechanisms 
(Rauwendaal, 1981) and mixing abilities.  Therefore, choice of a screw extruder depends 
upon several factors and among them, material properties are the most critical. Generally, 
single and twin screw extruders offer batch and continuous processing capabilities that appeal 
to many industries including the pharmaceutical industry, especially when there is a need to 




























1.3. Downstream processing of hot melt extrudates 
 
A number of downstream processing equipment has been developed utilizing the melt 
extrusion process that meets the requirements of final pharmaceutical dosage forms. In 
addition, dies attached to the extruder are varied in their size and shape for formulation 
development so as to attain the desired dosage level as well as the mechanical strength and 
other physical properties. Flat dies are utilized for production of films and sheets, circular 
dies are used for pelletization and spheronization whereas the annular dies are for making 
medical devices and tubings. Often, the extruded rod diameter or thickness will increase on 
exiting the die, which is partly due to the viscoelastic properties of the material and partly due 
to the melt pressure experienced in the barrels. This phenomenon is called die swelling. 
When extruded strands are milled, subsequent process such as tableting or filling into 
capsules becomes a batch or discontinuous process. In this case, the strands are conveyed and 
cooled down in the collector before the next processing step. Most of the marketed hot melt 
oral dosage forms containing extrudates were developed by milling and tableting the 
extrudates. The milling and tableting of hot melt extrudates require multiple unit operations 
as well as longer processing times. Thus, an alternative to the production of multiparticulate 
dosage forms using hot melt extrusion (HME) was investigated by introducing direct shaping 
techniques or hot melt pelletization. HME extrudates upon release were cleaved by rotary 
cutting to produce studs or HME pellets and this application shows the continuing adaption of 
technologies from the plastics industry to the pharmaceutical manufacturing. The pellets after 
a direct shaping process can be filled into capsules or sachets as a final dosage form. 




Figure 2. Common downstream processes. 
 
1.3.1. Auxiliary downstream processing 
1.3.1.1.  Cooling 
 
Chilled rolls are utilized as an intermediate process step, to cool down and control the 
temperature of extruded films. By adjusting the rotating speed of chilled rolls as well as the 
die slit opening, thickness of the film can be controlled. Two rolls with a defined slit opening, 
temperature and speed create a temperature gradient throughout the extruded film to cool it 
down in a controlled manner. Highly polished rolls with precisely controlled cooling system 
provide superior product characteristics and the thin extruded sheets can be immediately 
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1.3.1.2.  Conveying 
 
If the extruded material is brittle or needs a slow and steady cooling temperature, a conveyor 
belt can be used to support the extruded products to avoid or minimize untimely shaping that 
leads to destruction. Stainless steel conveyors with air, nitrogen or water cooling systems are 
used for the cooling of extrudates. The hot melt extrudates after cooling will then need to be 
milled or crushed in a subsequent process step. At the end, the powder can then be used for 
tableting or capsule filling. Maintaining and controlling the cooling rate is of major 
importance when the polymorphic form of the API has an impact on the in vivo performance 
of the drug. 
 
1.3.2. Direct shaping 
1.3.2.1.  Melt pelletization or spheronization 
 
Melt pelletization or fractionation of the extrudate strands has been achieved with a rapidly 
rotating cutter knife (Kipping et al., 2014; Young et al., 2002). A traditional strand pelletizer 
consists of blades or knives on a rotor and the strand is cut immediately after it leaves the die 
or being cooled by conveyor system. Due to the ability to cut simply, cleanly and quickly, 
rotary knife cutters are popular for many pharmaceutical applications. However, it is 
necessitated to use a very sharp knife during fractionation so as not to put too much pressure 
on surface and to obtain studs or pellets of consistent dimensions. The studs are instantly re-
shaded into uniform spherical pellets by further rounding in the spheronization step to 
increase dose precision and improve flowability. During spheronization, the temperature of 
extrudates can be controlled or maintained to soften it and be rounded by collisions with each 
other and the equipment wall to produce highly uniform spherical pellets. A drawback of this 
system is that uniform pellets with constant dimensions can only be obtained for rigid 
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materials, as extrudates composed of soft material will yield deformed pellets.  
Therefore, the operation mode of the rotating cutter can be by a start–stop mode or a 
continuous processing mode. In the start-stop mode, the strand is transported to the exact 
cutting position at which the conveyor belt stops and the cut is performed. After each single 
operation, the knife is repositioned and is prepared for the next cut action. During this time, 
the conveyor belt is moved to the desired position for the strand to be cut. This mode of 
operation leads to very accurate shapes of the products (Kipping and Rein, 2013). However, 
cutting in a start-stop mode provides a lower throughput rate and pellets with straight ends. 
Therefore, this technique is not ideal for hard or brittle materials.  On the other hand, in 
continuous mode, a high throughput rate can be obtained but the ends of the pellet may not be 
as straight or sharp. In both cases, challenges encountered include abrasion of the cutting 
blades and clogging of material during cutting which could be avoided by using Teflon 
coated knifes. The use of an air pressure nozzle could prevent the accumulation of pellets in 
the cutting zone. These improvements would help to alleviate some of the challenges 
encountered and offer a more widely applicable pelletizing system. Additionally, 
spheronization is one frequently being used as downstream processing method for 
pelletization. The process of pelletization in a traditional spheronizer has proven to be a 
common processing step and also production of homogeneous and good quality drug load 
pellets are successfully manufactured by using continuous spheronization systems (Pinto and 
Abreu, 2006). The design of the spheronizer includes of a frictional plate, which rotates 
within the confines of a cylindrical wall. The rounding of the extrudate into spheres or pellets 
is dependent on frictional forces. The forces are generated by particle–particle and particle–
equipment interactions. As the plate rotates, it throws the mass towards the wall of the 
cylinder where it rises up the wall and then falls back over the mass in the form of a “torus”. 
These interactions between pellets with the processing wall, plate and with each other 
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combine to collectively produce the rounding effect on the pellets (Newton, 2008).  For this 
reason, the disk is generally machined to have a grooved surface that increases the forces 
generated as particles move across its surface. Disks with two geometrical patterns are 
typically produced—a cross-hatched pattern with the groves running at right angles to one 
another and a line pattern, with the groves radiating radially from the center (Ghebre-Selassie 
and Martin, 2003). 
 
1.3.2.2.  Die face pelletization 
 
In the case of die face pelletization, the cutting process takes place when the soft molten 
material emerges from the extruder die plate as strands, which are immediately cut into short 
fractions, i.e. pellets, by a rotating knife. The possible advantage of die face pelletization is 
the production of equal length pellets, often spherical, with narrow particle size distributions. 
The spherical shape is brought about by the action of the cutting action taking place above the 
softening point of the material, when surface tension of the viscous matrix allows the 
fractions to contract and congeal into spherical pellets. However, the pellet morphology 
depends on formulation and process parameters.  Recently, a novel die was designed to 
include a direct pelletization /spheronization step. Proper temperature control of the extrusion 
die is important in the case of annular shaped extrudates and the traditional type of pelletizer 
is less suitable due to its configuration. Several patents have been granted for multifaceted 
direct pelletization /spheronization equipment with an underwater or cutting chamber with 
coolant which is then attached to the pelletizing apparatus, for realizing and stabilizing the 
pressure to press a cutting knife against a die plate, for preventing shaft vibrations, and for 
decreasing wear of the cutting knife due to the heat (Mürb, 2015; Pauley et al., 1988; 
Yamasaki et al., 1995).  
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1.3.2.3.  Calendering 
 
Calendering is a technique for in-line shaping of the extruded material in a fully continuous 
single-step process. It is the one of the downstream solutions that offers a continuous process 
by allowing an immediate final shaping of the extrudate using calendar rolls containing 
cavities. Using this technique, the freshly-extruded thermoplastic sheet is guided through a 
pair of temperature-controlled rolls containing tablet- or pill-shaped cavities, yielding bands 
that contain single tablet-shaped cores of the desired shape. During a calendering process, the 
molten extrudate is forced between one or more pairs of temperature controlled rolls to 
produce sheets that may also be deposited with tablet cores. This technique is already used in 
the plastics or confectionary industry to produce monolithic shapes (Vynckier et al., 2014). 
Meltrex® technology used in pharmaceutical applications offers calendering as one of the 
possible solutions to shape the molten strand on line, immediately after leaving the extruder. 
There will always some waste material at the sides of the tablets, which can be a disadvantage 
when dealing with highly valuable active ingredients. However, the ability to manufacture 
continuously through on line shaping of the product by calendering can be a major advantage 
when subsequent process steps are not required to produce the final dosage form (Breitenbach 
and Lewis, 2003). For co-extrusion, calendering can be a good solution since the shaping by 
the rolls will ensure that the outer layers are surrounding the inner core properly and the use 
of calendering to continuously shape a multi-layered co-extrudate into a monolithic fixed 
dose combination (FDC) dosage form was successfully evaluated by Vynckier et al. 
(Vynckier et al., 2015). 
 
1.3.2.4.  Injection and blow molding  
 
Injection molding as downstream processing is widely applied in the plastic processing 
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industry but is relatively new to the pharmaceutical industry. HME can be combined with 
injection molding to manufacture solid dosage forms in an efficient and semi-continuous 
process. For pharmaceutical application, these techniques can be applied to prepare solid 
dispersions or solutions in order to increase the bioavailability of poorly water-soluble drugs 
or to produce controlled-release preparations via the homogeneous embedding of drug 
particles in drug release-controlling polymers (Swarbrick, 2002).  During injection molding, 
the soften melt is injected into a mold containing cavities at high pressure. The melt cools and 
solidifies in the cavities (Vynckier et al., 2014). The final product is detached from each 
cavity after the mold has been opened. From the viewpoint of reliability and consistency, this 
technique is the most reliable option to produce final dosage forms with a unique shape, 
constantly and perfectly matching the specified dimensions. Quinten et al. (2009) 
demonstrated that injection molding of thermoplastic pharmaceutical formulations based on 
ethyl cellulose (EC) and polyethylene oxide (PEO) is a promising technique to prepare 
sustained-release matrix tablets. However, the major drawback for this approach is the 
dedicated and high equipment cost for the two-step co-injection molding process compared 
against other downstream processes. However, when a product has a specific shape or 
dimensional requirements, molding is the best alternative as a downstream processing 
technique (Vynckier et al., 2014). 
 
1.4. Significance of melt spheronization 
 
Using melt spheronization, various dosage forms, possibly as multi-unit dosage forms, for 
oral drug delivery can be manufactured. Compared to other pharmaceutical production 
processes, melt spheronization offers significance advantages and some of the major benefits 
are list as follow. 
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 Improve bioavailability:  With the increased number of poorly water-soluble drug 
substances in the new drug discovery pipeline, there is a need to increase the oral 
bioavailability of poorly water-soluble drug substances by various techniques 
including the formation of amorphous solid dispersions (ASD), crystalline solid 
dispersions, and co-crystals (Lang et al., 2014). 
 Solvent free: Melt spheronization is an anhydrous process and can provide 
significance advantages to drug substances which are highly susceptible to 
degradation by hydrolysis in the presence of aqueous or hydro alcoholic granulating 
media. 
 Short processing time: Unlike wet spheronization, melt spheronization does not 
require the drying step which will entail a longer processing time. However, in melt 
spheronization, materials will undergo thermal and mechanical stresses for a shorter 
residence time in the extruder which will be preferred in order to minimize or avoid 
any thermal degradation of the extrudates. 
 Minimum wastage: Due to self-wiping screw profile of the twin screw, near complete 
emptying of the equipment of any product introduced can be achieved and this 
minimizes product wastage. 
 Continuous process: The extruder coupled with the continuous feeding system of the 
material helps to avoid the multiple unit operations and promotes continuous 
manufacturing. In addition, the use of downstream pelletization equipment will 
enable the process to be fully continuous.  
 Flexibility and robustness: Melt extrusion operating parameters can be changed 
easily and continuously to change the extrusion rate or mixing action. Configuration 
of screw profiles can be easily optimized, dependent on the properties of feed 
materials and process conditions. Die plates can also be easily exchanged to alter the 
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extrudate diameter and allow the processing of many different formulations using a 
single machine, leading to efficient equipment utilization (Breitenbach, 2002). 
 Superior mixing: Distributive mixing and dispersive mixing of the screw profiles 
provide efficient mixing. The distributive mixing maximizes the division and 
recombining of the material while minimizing energy whereas the dispersive mixing 
ideally breaks droplet or solid domains into fine morphologies using energy at or 
slightly above the threshold level needed (Breitenbach, 2002). 
 Besides the significant attributes, high processing temperatures required, however, 
tend to be the limitation factor for processing thermally sensitive compounds and yet, 
the combination of HME with other technologies, such as nanotechnology (Miller et 
al., 2007) powder coating (Sauer et al., 2007) and complexation (e.g., cyclodextrins) 
(Lu et al., 2014) have demonstrated the versatility and inclusiveness of HME. 
 
1.5. Hot melt extrudate pellets as multiparticulate dosage form 
 
The concept of multiparticulates as multi-units dosage form was initially introduced in the 
early 1950s. Multiparticulates may exist as pellets, granules, sugar seeds (non-pareils), mini-
tablets, ion-exchange resin particulates, powders and crystals, with drugs being entrapped in 
or layered around cores (Tang et al., 2005).  Pellets are core components of a multiparticulate 
drug delivery dosage form that offers considerable therapeutic advantages such as reduced 
irritation of the gastrointestinal tract, unaffected by the gastric emptying time, reduced risk of 
dose dumping and flexibility in the design of a controlled release system. Pellets are very free 
flowing, mechanically strong and can be produced with narrow size distributions. The highly 
spherical and well defined pellets make them excellent substrate to be coated as they can be 
coated evenly in a fluid bed system for drug deposition or encapsulation purposes.  Moreover, 
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pellets are versatile as components in a variety of dosage forms due to their spherical shape, 
good mechanical properties and ability to release their active constituents stored within in a 
predictable manner when delivered in hard gelatin capsules or tablets. Compared with other 
drug delivery systems such as a single unit tablet dosage form, pellets have several key 
advantages:  
 improved bioavailability 
  ease of administration  
 less irritation in the gastrointestinal tract 
 low the risk of dose dumping  
 dose flexibility 
In general, the multiparticulate dosage forms  are  pharmaceutical  formulations  in  which  
the  active pharmaceutical  ingredient  (API)  is  present  as  a  number  of  small  independent  
subunits and act in unison to deliver the recommended total dose. These subunits are 
normally collated by filling into a sachet, capsule or compressed into a tablet (Varum et al., 
2010). The dose is then the sum of the quantity of the drug in each subunit and the 
functionality of the entire dose is directly correlated to the functionality of the individual 
subunits (Lopes et al., 2006). Other advantages of the divided drug dose include easy 
adjustment of the strength of the final dosage unit by changing the number of 
multiparticulates in the dosage unit, administration of incompatible drugs in a single dosage 
unit by separating them in different multiparticulates, and combination of multiparticulates 
with different drug-release rates to obtain the desired overall release profile (Tang et al., 
2005).  In addition, pellets are utilized for both immediate release and a number of different 
controlled or special release applications (Umprayn et al., 1999). Pellets shape are defined in 
general, as spherical or semi-spherical, free-flowing granules with a narrow size distribution, 
typically varying in diameters between 500 and 1500 μm. Due to their uniformity in size, 
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pellets offer biopharmaceutical advantages in terms of more even and predictable 
distribution, and transportation in the gastrointestinal tract, which is fairly independent of the 
nutritional intake (Krämer and Blume, 1994). In recent years, pellets dosage form has also 
gained significant interest not only because of their pharmacological advantages but also due 
to their ease of processibility and administration for pediatric and geriatric patient population. 
Pellets containing cellulose acetate phthalate extrudates manufactured using a ram extruder 
was reported for the effect of pellet geometry on the dissolution rates (Rippie and Johnson, 
1969). Similarly, sustained release pellets containing thermoplastic polymers were 
manufactured using hot melt extrusion (Mank et al., 1989); (Mank et al., 1990).also 
investigated the possibility of using hot-melt extrusion technology to produce sustained-
release pellets. 
 
1.6. Characterization of hot melt extrudates pellets 
 
Evaluation of formulations produced via HME is done using several methods, depending 
upon type of dosage form developed. In addition, physical and chemical properties of 
multiparticulates systems are very important as each subunit represents part of the total and 
collectively act to deliver the recommended dose, in the manner and rate as they had been 
designed for. Therefore, it is important to ascertain the specific physicochemical properties of 
individual subunits or a fraction of them such that their behaviors confer the attributes for the 
desired pharmaceutical application. By definition, solubilization in HME primarily occurs by 
solid dispersion or solid solution in which individual molecules are randomly oriented with 
respect to one another and exist in various conformational states. Analytical characterization 
of a solid dispersion is to focus at accurately determining solid-state drug–polymer 
miscibility, crystallization kinetics to further assist in setting the polymer selection criteria. 
On the other hand, characteristics of multiparticulates are further characterized for 
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flowability, size distribution, hardness and shape uniformity to ensure content uniformity, 
physical stability and desired release properties.  
 
1.6.1. Powder X-ray diffraction (PXRD)  
 
For melt extrusion, PXRD can be supported in two major areas, development stage where 
formulation screening for miscibility of amorphous drug and the polymer and product 
characterization stage where determination of residual amount of crystallinity and storage 
stability of melt extrudate. Crystallinity properties of hot-melt extruded dosage forms have 
been widely evaluated using PXRD as the crystallinity is reflected by a characteristic 
fingerprint region in the diffraction pattern. In general, if the fingerprints of the drug and 
carrier do not overlay one another, the crystallinity of the drug and polymer after HME can be 
elucidated by using PXRD.  
The principle of PXRD is based on Bragg's law, in which parallel incident X-rays strike the 
crystal planes and are then diffracted at angles related to the spacing between the planes of 
molecules in the lattice. Thus, PXRD can be used to differentiate between solid solutions and 
solid dispersions. It is important to note here that PXRD detects the presence of molecular 
order (i.e. crystalline state) and not disorder (i.e. amorphous state). The amorphous state is 
rather implied by the absence of characteristic Bragg’s peaks and hence, the associated long-
range symmetry order (Saleki-Gerhardt and Zografi, 1994). However, the sensitivity of the 
PXRD technique is limited and cannot generally detect crystallinity accurately, in amounts of 




1.6.2. Differential scanning calorimetry (DSC) 
 
DSC has been widely used to study the thermal properties of materials used in HME. DSC 
can be used for the quantitative detection of transitions (e.g. glass transitions, Tg) in which 
energy is required or liberated (i.e. endothermic and exothermic phase transformations). 
Generally, the hot melt extrudates are scanned and compared with the physical mixture 
containing the same amounts of drug, polymeric carrier and other excipients. The lack of 
crystalline melting peak of an API in the DSC scan of the hot-melt extrudate indicates that 
the drug is present in an amorphous rather than crystalline form. 
 
1.6.3. Thermogravimetric analysis (TGA) 
 
TGA is usually used to measure thermally induced weight loss of a material in a formulation 
as a function of temperature. Thermal stability of a formulation can be evaluated from the 
information of weight loss or gain from TGA. In addition, TGA can be used as a screening 
tool for thermal stability of different materials that could be used in HME. 
 
1.6.4. Microscopy and surface morphology 
 
Microscopy is one of the best methods to study the crystalline properties of solid dispersion 
system. Both optical and electron methods are suitable to examine the surface morphology of 
samples to investigate for the presence of crystalline materials. Though it is not common, it is 
also possible to obtain reliable particle size information using these techniques. Additionally, 
scanning electron microscopy (SEM) is used to examine the surface morphology and cross 
section of pellets and the microstructures in the pellet surfaces. SEM images were also used 





1.6.5. Size and size distribution  
 
Particle size and size distribution of the pellets can be determined by sieve analysis, laser 
diffraction, 2D and 3D imaging methods among others. The sizing of pellets is essential 
because particle size and the associated surface area possess significant influence on the drug 
release kinetics. Particle size distribution, mean ferret diameter, geometric mean diameter, 
mean particle width and length are some of the size parameters by which size of pellets can 
be described and in most of the cases, particle size determination of the larger pellets is 
carried out by the use of sieves aided by a sieve shaker. In some cases, it has also been 
reported that vernier calipers were used to determine the size of pellets. 
 
1.6.6. Pellet shape 
 
Sphericity of the pellets is the most important particle characteristic and various measurement 
methods have been used to determine it. A shape factor is often measured by estimating the 
amount by which the projected image of the object deviates from an equivalent circle and 
calculations are by using the projected area of the object and its circumference. For perfectly 
circular projected image, the shape factor should be 1 while a value of 0.6 or higher describes 
a particle of reasonable sphericity. Visual inspection of pellets by microscope and 
stereomicroscope is another method to determine shape of pellets. The angle of repose, a 
measure of flowability, is also reported as an indirect indication of the circularity of pellets 
and is calculated by the ratio of double the heap height and heap radius by fixed funnel 
method measured after a certain amount of pellets are allowed to fall from a given height 
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through a specific orifice. 
 
1.6.7. Tensile strength 
 
Many test methods were established for characterization of the mechanical or tensile strength 
of pellets. A 5 kg load cell with tensile apparatus was used to determine the tensile strength of 
pellets and the pellet is strained until failure occurs. The load is recorded and the tensile 
strength is calculated applying the load value at failure and the radius of the pellet.  The 
mechanical characteristics of pellets could also be characterized using a texture analyzer.  
 
1.6.8. Loss on drying 
 
In general, for both wet and melt extrusion spheronization, loss on drying method is 
characterized for the determination of the water content in the extrudates and the water 
content was calculated as the percent weight loss on drying, based on the dried mass. 
 
1.6.9. Drug release 
 
Drug release from pellets is significantly influenced by the composition, hardness and size of 
pellets. In vitro dissolution has been identified as an important characterization tool during 
both drug development and routine quality assessment. In addition, the drug release profiles 
of pellets also depended on the nature of the carrier, aqueous solubility of the drug, physical 




1.7.  Research gaps in melt spheronization 
 
The interest in pellets as a dosage form has increased continuously for their multiparticulate 
nature which offers important pharmacological and technological advantages over 
conventional single-unit solid dosage forms. Many reports have been presented for pellets 
developed by wet extrusion spheronization. Process and formulation impacts of pellets after 
wet extrusion process were prudently studied.  
The lack of any systematic study on development and characterization of solid dispersion 
multiparticulates (pellets) by melt extrusion spheronization had been identified as one of the 
key research gaps.  Additionally, formulation variations and in-depth understanding of 
process conditions such as melt extrusion temperature, spheronization speed and duration on 
the physicochemical properties of pellets were yet to be fully elucidated. In this thesis, the 
physicochemical properties of the pellets after melt spheronization were carefully evaluated 
to develop a fundamental understanding of the formulations and their related interactions 
with process conditions. Viscoelastic properties of melt pellets and their impact on formation 
of spheronized pellets were also considered as one the main areas to be focused on.  
In addition, the presence of water insoluble and soluble spheronization aids and their physical 
properties such as particle size and molecular weight on the physicochemical properties melt 
pellets needed to be investigated.  Geometry of spheronizer, especially on the frictional plate, 
was considered as one of the important input for understanding the process responses like 
pellet effective yield, size and shape. As pellets offer biopharmaceutical advantages in terms 
of predictable distribution and transportation in the gastrointestinal tract, it was important to 
understand the drug release properties due to formulation variances as well as influences of 
process conditions. Therefore, pellets before and after spheronization were also evaluated by 















2. OBJECTIVES AND HYPOTHESIS 
 
A considerable amount of literature reports has focused on wet spheronization and the 
application of experimental design on the extrusion spheronization process. Factors that have 
been studied and included in the experimental designs were: rate of extrusion, water content, 
screen size, spheronizer speed, spheronization time and spheronizer load.  In terms of 
formulations and excipient aspects, several parameters such as the presence of soluble or 
insoluble fillers, surface active agents, pH adjusters, drug load and ratio of filler to drug, 
different grade of excipients among others have also been evaluated (Baert et al., 1993; Heng 
and Koo, 2001; Law and Deasy, 1998; Sinha et al., 2005).  
Melt spheronization process is a relatively new process and very limited studies have been 
reported. Production of melt pellets and properties of spherical pellets for controlled release 
application has been reported by Young et al. (Young et al., 2002). Physicochemical 
properties of controlled release pellets using melt spheronization process were also discussed 
by the same authors (Young et al., 2002). 
Nevertheless, the influences of spheronization conditions and the configuration of the 
spheronizer’s geometry on properties of melt pellets, such as shape in particular had not been 
well investigated. In addition, compositions, formulations factors and viscoelastic properties 
of formulations that affect the sphericity of pellets prepared by melt extrusion spheronization 
were yet to be established. Therefore, understanding the impact of spheronization process 
under different conditions and coupled with variations in the viscoelastic properties of 
formulations offered the new insights for this study, in the development work by applying the 
melt spheronization technology as a direct rotary shaping process for hot melt extrudates.  
The main hypothesis of this project is formulation composition, spheronization conditions, 
and / or configuration of the spheronizer’s geometry influence(s) physicochemical properties 
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of hot melt extrudates by melt spheronization process. 
The sub-hypotheses of this thesis include: 
 Melt spheronization process could be a viable downstream processing method of 
using hot melt extrudates to prepare pharmaceutical drug delivery systems such as 
pellets or granules. 
 Inclusion and concentration of a plasticizer as an extrusion aid would impact 
physicochemical properties of hot melt extrudates when they were subjected to direct 
rotary shaping process. 
 Properties of excipients, in terms of particle size and molecular weight, in the 
formulation were important factors for pellet formation by melt spheronization and 
investigations on properties of excipients in the formulation would provide a better 
understanding the formative process of the melt pellets.  
To test the abovementioned hypotheses and to accomplish the objectives, the following 
studies would be carried out: 
 To develop hot melt extrudates containing water soluble extrusion aids and evaluate 
physicomechanical properties of spheronized multiparticulates (pellets) via melt 
spheronization method. 
 To investigate the incorporation of a meltable drug as an unconventional plasticizer 
and to provide scientific assessment relating to the impact on physicochemical 
properties of pellets. 
 To design and study the impact and influence of physical properties of water 




The outcomes of this project would provide new insight on the importance of spheronization 
conditions as well as physical properties of extrusion and spheronization aids for successful 
melt spheronization. By investigating the pellet rounding process and evaluating 
physicochemical properties of the pellets, a better understanding of the impact of the process 














3. MATERIALS AND METHODS 
3.1. Materials 
 
Ibuprofen (IBU) was purchased from Sequoia Research Products (Pangbourne, UK). 
Copovidone (CPV) was obtained from BASF (Ludwigshafen, DE). Polyethylene glycol 
(PEG) 4000 was provided as sample from Sasol (Hamburg, Germany). Three commercial 
grades of microcrystalline cellulose (MCC), i.e. Avicel PH 101®, Avicel PH 102® and 
Avicel PH 105® were obtained from FMC Polymer (Ireland).  Three pharmaceutical grades 
of hydroxypropyl cellulose (HPC), i.e. Klucel® EF, GF and HF Pharm were obtained from 
Hercules (Wilmington, DE, US). Colloidal silicon dioxide (SiO2) was obtained from Cabot 
Corporation (Illinois, US). 
 
3.2. Methods 
3.2.1.  Blending 
 
Excipients with or without API were sieved through a 500 micron aperture size mesh. The 
mixtures were blended in a 2L container using the Turbula blender (TURBULA® T2F, Willy 
Bachofen, Muttenz, CH) at 42 rpm (maximum speed) for 5 min. Prior to hot melt extrusion, 
approximately 2 g of each bend was measured for moisture content using a moisture analyzer 




For crystallinity determination, approximately 10 g samples of MCC of the various grades 
were cryo-milled (Cryomill, Retsch, Haan, DE) with 100 steel balls of 10 mm diameter. The 
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mill was filled with liquid nitrogen and then operated for 20 min, rested for 30 min before 
continuing and repeated for a total milling time of 60 min. The milled MCCs were stored in 
refrigerator at 5°C till required for further characterization.  
 
3.2.3. Extrusion-Fractionation Process 
3.2.3.1.  Experimental set up 
 
Co-rotating twin-screw extruder (Nano-16, Leistritz, Sommerville, NJ, US) with a volumetric 
feeder (Tuf-Flex™ 300, Schenck AccuRate, Whitewater, WI, US) was used. The screw speed 
was fixed at 70 rpm. A constant screw speed and feeding rate throughout the process is 
important as the combination of these two factors establishes the level of fill in the extruder. 
This combination helps to deliver a constant material flow rate through the extruder thereby 
the shear stress and residence time experienced by the material remain relatively constant.  A 
cylindrical die with opening of 2 mm diameter was connected to the outlet of extruder to 
manufacture extrudate strands or rods. The blend was mixed and conveyed by the co-rotating 
twin screws in the barrel sections maintained at set controlled temperature. Melt pressure and 
extruder screws’ torque were monitored throughout the extrusion process. The melt pressure 
of a polymer was dependent on the feed rate and screw speed. However, with a constant 
screw speed and feed rate employed, the melt pressure only depended on the blend’s 
property, chiefly the components’ molecular weights and miscibility of the polymer blend 
ratios. Extrudate strands from HME process were in contact with environmental room air 
once released from the die. The strand was transported by the conveyor belt into an automatic 
rotatory fractionator (Varicut, ThermoFisher Scientific, Karlsruhe, DE) for fractionation. The 
setting of the fractionator was adjusted to achieve a continuous feed at the inlet of the 
fractionator and maintained throughout the fractionation process. Fractionated melt pellets 
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were collected into a glass container kept at ambient condition for downstream 
spheronization process. Overview of experimental set up is as shown in Figure 3. 
 
 
Figure 3. Experimental set up of melt spheronization process. 
 
3.2.3.2.  Screw configuration 
 
After feasibility runs, three different pitch heights of screw elements with co-rotating, 
conveying and free meshing were selected. The naming system of each screw element can be 
found in Figure 4 . For the sake of consistency and to standardize the process, the same screw 





Figure 4. Naming system of screw element. 
 
 
Figure 5. Screw Configuration. 
 
3.2.3.3.  Process conditions 
 
A defined set of extrusion process conditions with respect to conveyor speed and fractionator 
setting were selected after the feasibility runs and shown in Table 1. 
  
x x x - x - x x - x x
GFA-3-10-30 XX = Length of screw element
GFA-3-15-30
GFA-3-20-30 XX = Pitch






Table 1. Parameters of the feasibility studies carried out with the respective formulations using 
the HME process 
Parameters Study (A) Study (B) Study (C) 
Zone 1 (C) 80 80 80 
Zone 2 (C) 130 (150*) 120 130 
Zone 3 (C) 130 (150*) 120 130 
Zone 4 (C) 130 (150*) 120 130 
Feed Zone (C) 25 25 25 
Screw speed (rpm) 70 70 70 
Feed rate (rpm) 150 110 150 
Conveyor speed (rpm) 16 10 17 
Fractionator setting L3 (1.5 mm) L4 (2.0 mm) L3 (1.5 mm) 
* For formulation without processing aid (PEG4000), temperature at zone 2 to 4 was set at 150C. 
 
3.2.4. Spheronization  
 
The fractionated pellets were placed into a spheronizer (Multibowl M120, Caleva, Sturminster 
Newton, Dorset, UK).  Temperature of spheronizer’s jacket was maintained by connecting a 
water circulator (AD07R, PolyScience, Niles, IL, US) at a set controlled temperature. 
Spheronization processes were performed at rotational speeds of 1000 to 3000 rpm. A minimum 
batch size of 50 g was selected for each spheronization run. Rotating frictional plates fitted with a 
diameter of 119 mm with cross-hatch patterned grooves (A) and line patterned grooves (B) were 
evaluated. Pellets fraction in 0.5 – 1.8 mm range were sieved, weighed before and after 









Figure 6. Rotating frictional plate with cross-hatch patterned and line patterned grooves.  
 
3.2.5. Melt pellets preparation and characterization process overview 
 
Processes included for preparation of melt pellets were hot melt extrusion, fractionation, pre-
spheronization characterization, spheronization and post-spheronization characterization. The 
details of the characterization methods are described in section 3.2.6 and overviews of 
characterization steps are shown in Figure 7. 
(A) – Cross-hatch patterned grooves frictional plate – front and angled views 
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Figure 7. Overview of the preparation and characterization of melt pellets. 
 
3.2.6. Characterization of melt extrudates and pellets 
3.2.6.1.  Loss on drying 
 
Percent moisture uptake of the pellets was measured using loss on drying (LOD) method. 
LOD of pellets before and after spheronization were determined using a moisture analyzer 
(MB45, Ohaus, Pine Brook, NJ, US). Pellets were heated at 5°C/min to 105°C and held at 
this temperature for 15 min. LOD was determined by the difference between the initial 
weight (Wi, mg) and the final weight after equilibration (Wf, mg) and was calculated as 
follow: 
LOD =  [
(Wi – Wf)
Wi
] X 100 %                (1) 
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3.2.6.2.  Extrudate hardness and brittleness (fracturability) 
 
Extrudate exterior hardness and brittleness (fracturability) were measured after cutting the 
extrudate strands with a craft knife adaptor and measurements made using the texture 
analyzer (TA.XTPlus, Stable Microsystems, Surrey , UK). Samples of extrudate strands cut 
to 3 cm length and 0.8 to 1.4 mm in diameters were prepared for the test. Ten measurements 
were performed on each formulation. Each sample was placed on a heavy duty texture 
analyzer platform with one aluminum plate and sample was cut by craft knife on a load cell at 





Figure 8.  TA.XTPlus texture analyzer with heavy duty platform and craft knife adaptor. 
 
3.2.6.3.  Percentage yield (Ye%) 
 
Efficiency of spheronization process was measured in terms of percentage yield (Ye%). The 
yield range was set up for pellets within 0.5 mm to 1.8 mm as being in the desired size 
fraction. Weight of pellets retained within 0.5 mm to 1.8 mm was determined before and after 
spheronization and Ye% was calculated as per equation  
𝑌𝑒% =  
 WEIGHT  after spheronization
WEIGHT before spheronization
 x 100              (2) 
 
Heavy duty platform 
Craft knife adaptor 
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3.2.6.4.  Particle size and size distribution 
 
Particle size distribution of pellets was evaluated before and after spheronization using sieves. 
Sieves of aperture sizes 1.8, 1.4, 1.0, 0.8 and 0.5 mm were used. A sample was weighed and 
loaded onto the top screen of the sieve stack place on a sieve shaker (AS 200, Retsch GmbH, 
Haan, Germany). The sieve shaker was vibrated at 70 Hz over 5 min intervals. The weights of 
fractions on the sieves and the collection pan were determined and recorded after each 
interval. The weights of fraction retained on each sieve and collection pan were determined. 
This step was repeated with 5 min sieving cycles until the weights retained for all the sieves 
and collection pan became consistent, within ± 0.5 %.  A smaller Span value is desired as it 




                  (3) 
 
where D10, D50 and D90 were diameters of pellets at the 10, 50 and 90 percentiles of the 
cumulative percentage weight plot, respectively. 
 
3.2.6.5.  Two-dimensional shape factors 
 
A polarized microscope (Microphot-FXA, Nikon, Tokyo, Japan) was used for two 
dimensional image analyses. The projected images of pellets were captured using a camera 
(DP72, Olympus, Tokyo, Japan). Captured 2D images only showed the more horizontally 
stable dimensions of the pellets.  
Minimum of 50 pellets were arranged manually to ensure that all pellets were well separated 
and the longer dimensions were roughly pointing in the same orientation. Image analysis 
quantified the cross-section area occupied by each pellet. The images were then analyzed 
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using the Image Pro Premier software (Image-Pro Premier 9.1, Media Cybernetics, Rockville, 
MD, US) to obtain roundness (R) and aspect ratio (AR). The equations for calculating R and 
AR are given as follow: 
R =  
Perimeter2
(4∗ ∗Area)
                  (4) 
 
AR =
Major Axis of equivalent ellipse
Minor Axis of equivalent ellipse
                            (5) 
 
3.2.6.6.  Rheological characterization 
 
A rotational rheometer (HAAKE MARS II, ThermoFisher Scientific, Karlsruhe, Germany) 
with 25 mm parallel plate geometry and a heating capacity of up to temperature 150C was 
used. Powder blends and pellets were carefully prepared and loaded directly between the 
plates. From the parallel plate rheological measurements, G’ (storage modulus), G’’ (loss 
modulus) and |ƞ*| (complex viscosity) can be calculated. 
G′ =  
2hMo sin δ
πr4φo
                             (6) 
 
Gʺ =  
2hMo cos δ
πr4φo
                 (7) 
 






)𝟐]                (8) 
 
where h is the gap height between the parallel plates, Mo is torque amplitude,  is the phase 
angle that represents the time dependent behavior of viscoelastic materials, o is the angular 
amplitude and  is angular velocity of oscillation. 
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G′ indicates energy stored per unit volume, and G″ explains energy dissipated per unit 
deformation rate per unit volume. G′ is proportional to the extent of the elastic component 
(contributed by crosslinking, entanglement, and/or aggregation) of the system, and G″ is 
proportional to the extent of the viscous component (contributed by the liquid-like portion) of 
the system. Typically, the strength of interaction of internal structure is measured by the 
magnitude of damping factor, tan δ. The smaller the tan δ (or the greater G′) is the stronger 
the interaction between microstructure. 
tan  =  
G"
G′
                         (9) 
 
3.2.6.7.  Powder X-ray diffraction (PXRD) 
 
A benchtop X-ray diffractometer (Miniflex™ II, Rigaku Corporation, Shibuya-Ku, Tokyo, 
Japan) along with aluminum specimen holders of 40 mm diameter and thickness of 2 mm 
were used to detect any crystallinity present in the extrudates. Diffraction patterns were 
obtained using a 2θ range of 3° to 90°, with a 0.02° step width and a scan speed of 2°/min in 
a continuous scanning mode. 
 
3.2.6.8.  Thermal gravimetric analysis (TGA) 
 
Temperature-dependent stability of IBU and individual excipients were examined by TGA. 
Samples were heated up to 300°C using a thermal gravimetric analyzer (TGA Q500, TA 





3.2.6.9.  Differential scanning calorimetry (DSC) 
 
Determination of the glass transition temperature (Tg) of the blends and extrudates before and 
after spheronization were measured by using the DSC (Q2000, TA Instruments, Newcastle, 
DE, US). As ibuprofen (IBU) has a melting point around 78°C, the extrudates samples, 
placed inside an aluminum pan sealed with a non-hermetic lid, were heated from -50°C to 
170°C. Depending on the nature of formulation, either the standard DSC method with a 
heating rate of 10°C/min or 20°C/min was used.  
 
3.2.6.10. Fourier Transform Infrared Spectroscopy (FT-IR) 
 
The FT-IR spectra of the pellets were recorded with FT-IR spectrometer (Nicolet iS10, 
Thermo Scientific, West Palm Beach, FL, US) with 64 scans from 4000 cm
-1




3.2.6.11. Scanning electron microscopy (SEM)  
 
Pellets samples were mounted on studs using double-sided carbon tape. Images by SEM 
(JSM-6010LV, Jeol, Tokyo, Japan) were obtained for the prepared samples for visualization.  
 
3.2.6.12. Drug release 
 
Drug release profiles for IBU formulations were conducted using USP dissolution test 
apparatus II (Vision Elite 8, Hanson Research Corporation, Chatsworth, CA, US) with 
stirring speed of 75 rpm at 37°C ± 0.5°C in pH 7.2 dissolution phosphate buffer media. Size 
00 gelatin capsules were filled with IBU pellets for drug release testing and sinkers 
(CAPWHT-XS, Quality Lab Accessories L.L.C, Telford, PA, US) were used to prevent 
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capsules from floating. During the dissolution run, media samples were collected 
automatically via a continuous flow-through mode and at every 1 minute for at least 60 min 
of the run, UV measurements were made using in situ fiber optic probe (Rainbow Dynamic 
Dissolution Monitor® System, Pion Inc., MA, US) and analyzed using Au PRO software 
version 5.1.1 (Pion Inc., Billerica, MA, US).  To compare the dissolution profiles of 
formulations before and after spheronization, the similarity (f2) and difference (f1) were 
evaluated. The f2 and f1 factors are suggested by the US Food and Drug Administration 
(FDA) for determination of the similarities and differences between the dissolution data 
collected in a stability study (FDA, 1997). The dissolution profiles were considered similar 
when f2 was greater than 50 and f1 data less than 15. 
𝑓2 = 50 log {[1 + 
1
n




 x 100}                                                    (10) 
 
𝑓1 =  {[∑ |Rt − Tt|
n
t=1 ] / [∑ Rt
n
t=1 ]}x 100            (11) 
 
where n is the number of time points, Rt, is the dissolution value of the reference (pre-change) 
batch at time t, and Tt, is the dissolution value of the test (post-change) batch at time t. 
 
3.2.6.13. Statistical analysis on physicochemical properties of pellets 
 
The results were analyzed using the Minitab® statistical software (Version 17.0; State 
College, State College PA, US) and Microsoft Excel 2010 (Version 14; Microsoft, Redmond, 
WA, US). A p < 0.05 was considered statistically significant. GraphPad Prism (Version 5.02; 




3.2.6.14. Multivariate Data Analysis 
 
Multivariate data analysis (The Unscrambler®, version 9.8, Camo Inc., Bangalore, India) was 
performed to evaluate the influence of the various spheronization aids on the rheological 
properties of melt pellets. Melt pellets with different spheronization aids and their rheological 
properties were entered as inputs and the software generated loadings plots as outputs. A 
projection view of the inter-variable relationships among the parameters of interest was 
provided as the loadings plot (Esbensen et al., 2002). 
 
3.2.6.15. Target transformation factor analysis (TTFA) 
 
TTFA was used to confirm the presence of a particular component in a set of FT-IR spectra. 
TTFA is an established chemometric algorithm for evaluating a set of spectroscopic data for 
the presence of a target spectrum commonly called a target vector (Malinowski, 2002). This 
approach works by checking if a reference pure component spectrum is present in an 
experimental data set  (Srilakshmi et al., 2007). The reference spectrum of a suspected 
component or crystal form is projected onto the measured spectroscopic data to check 














4. RESULTS AND DICUSSION 
4.1.  Study A. Development and evaluation of physicomechanical properties of CPV-PEG 
solid dispersion multiparticulates (pellets) 
4.1.1. Preparation of CPV-PEG solid dispersion pellets by melt spheronization approach 
4.1.1.1.  Rational for excipients selection 
 
Selection of a polymer carrier system is critical for a successful development of formulation 
and HME processes (Lang et al., 2014). Hydrophilic carriers, including polyvinylpyrrolidone 
and polyvinylpyrrolidone-co-vinyl acetate (CPV), polyethylene glycols (PEGs), some 
celluloses, polymethacrylate, and polyvinyl caprolactam–polyvinyl acetate–polyethylene 
glycol graft copolymer have been successfully used to improve the solubility and 
bioavailability of water insoluble compounds using HME techniques (Lyons et al., 2007). 
Uses of CPV in HME have been reported in many reports due to its thermoplastic properties 
and improved solubility  (Kolhe et al., 2013b; Lang et al., 2014; Pudlas et al., 2015; Shah et 
al., 1998; Surikutchi et al., 2013; Yang et al., 2016; Yu, 2001). CPV is also more 
hydrophobic compared to other polyvinylpyrrolidone polymeric carriers and less brittle due 
to its vinyl acetate component (Bühler, 2005). CPV (Figure 9A) was selected as its reported 
thermoplastic properties requires only a temperature of just above 150°C for extrusion.  For a 
HME process, the addition of processing aids is sometimes recommended to lower the 
required process temperature which, if too high, may degrade temperature-sensitive drugs or 
other component polymers (Kidokoro et al., 2001). Plasticizers are often considered as 
processing aids and commonly encountered plasticizers include triethyl citrate, tributyl 
citrate, triacetin, PEG and propylene glycol (Britain, 1941; Kolhe et al., 2013a, b; Vélaz et al., 
1998). PEGs are semi-crystalline polymers with wetting, solubilizing and surface active 
properties (Vélaz et al., 1998) and have been used extensively in the solid dispersion 
preparations.  The biocompatible and biodegradable PEG polymer has also been associated 
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with adhesive and flocculent properties (Özgüney et al., 2009).  Different grades of PEGs 
have been reported to possess good solubility and thermal stability and could be incorporated 
for improving the solubility of drug substances, to enhance dissolution and bioavailability.  In 
this study, PEG 4000 with average molecular weight (Mn) 4000 (Figure 9. B) was selected as 
a plasticizer to be used in the HME formulations for its low melting point, rapid solidification 









Figure 9. Molecular Structure of (A) CPV and (B) PEG. 
 
4.1.1.2.  Experimental design and set up 
 
A full factorial DOE, 3 factors and 4 levels (4 x 4 x 4 = 64 runs) was applied to evaluate the 
influence of concentration of PEG 4000, spheronization speed, run duration and their effect 
on size, size distribution and shape of CPV-PEG pellets. The formulation components were 
first blended in a Turbula blender and then transferred to the twin screw extruder via a 
volumetric feeder. The screw speed was set at 70 rpm and kept constant. Glass transition 
temperature (Tg) of CPV was 107⁰C as measured by DSC. For formulation with a processing 
aid (PEG 4000), Tg was reduced due to plasticizing effect of PEG. The range of melt 
extrusion temperature reported in literature reports cover between 10 - 80⁰C above the Tg or 
melting temperature (Tm) of the drug (Gupta et al., 2014; Reintjes, 2011; Surikutchi et al., 
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2013; Wan et al., 1993). Hence, feasibility runs had to be performed at various extrusion 
temperatures, screw speeds and feed rates to ensure that a continuous extrusion process under 
controlled conditions could be achieved. It was found that the temperature range for melt 
extrusion of CPV was 120-160⁰C and for that with a processing aid or plasticizer with the 
model drug was 110-130⁰C. However, it was not possible to set the same extruder setting for 
all formulations that could be could be directly fractionated.  Temperatures of extruder’s 
barrels were set as per Table 1.  For each formulation, a minimum of 800 g extrudates was 
manufactured and fractionated. Extrudate strands from each formulation were collected 
during the extrusion process for hardness and fracturability tests. Size analysis using sieves 
was performed to determine the size and size distribution of fractionated pellets before 
spheronization. The spheronizer (M120, Caleva, Sturminster Newton, Dorset, UK) with 
cross-hatch patterned grooves (P) frictional plate of 119 mm was used for spheronization 
process. The spheronizer bowl was unheated, and therefore had the temperature of the room, 
about 25°C.   A sample size of 50 g pellets from each formulation (Table 2) was collected 
and spheronized. Samples at each spheronization condition (Table 3) were collected and 








Table 2.Compositions of different formulations 
Materials Formulation code 
F1 F2 F3 F4 
% Processing aid (PEG4000) 0 5 10 15 
% Polymer carrier (CPV) 99 94 89 84 
% Glidant (SiO2) 1 1 1 1 
 
 
Table 3.Spheronization process parameters 








Figure 10. Design of experiments.  
Formulation 
(Concentration of PEG) 
•  0% 
•  5% 
• 10% 
• 15%  
Spheronization Speed 
• 1000 rpm 
• 1500 rpm 
• 2000 rpm 
• 2500 rpm 
Spheronization duration 
• 15 min 
• 30 min 
• 45 min 
• 60 min 
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4.1.2. Effect of concentration of processing aid (PEG) on physicomechanical properties of 
pellets  
4.1.2.1.  Pre-spheronization characteristics 
4.1.2.1.1. Rheology of molten pellets 
 
Oscillatory rheometry is a sensitive technique used to characterize the viscoelastic flow 
behavior of polymer melts under the processing conditions used and set temperatures, for 
which their rheological properties depend greatly upon molecular weight and structure 
together with the component constituents present. Dynamic frequency sweep test evaluates 
microstructure characteristics of viscoelastic materials and it is commonly used (Landel and 
Nielsen, 1993). In addition, long chain polymers are potentially viscoelastic with properties 
of both viscous liquids and elastic solids, depending on the time scale of the deformation 
(Britain, 1941). Rheology properties of fractionated pellets from each formulation were 
evaluated for their viscoelastic properties after extrusion for the assessment of the impact of 
formulation and processing on the physicomechanical properties of pellets. The measurement 
was conducted at constant temperature of 130C for formulations F2-F4 and at 150C for 
formulation F1.  Within the linear viscoelastic region of the materials, a strain of 0.1 % for 
formulation F1 and that of 5 % for formulations F2 to F4 were applied to all samples.  The 
sample was subjected to a strain with frequency varying from 100 to 0.1 Hz.  Figure 11 
shows that viscosity decreases with the increasing PEG concentration indicating the 
plasticizer effect of the PEG. Each formulation showed greater G” compared to G’ (Figure 
12) indicating that samples were more viscous at the tested conditions. Viscous properties of 
formulation F1 were higher compared to other formulations, F2 to F4, tested at lower test 
temperature. This observation explained why formulation F1 required higher extrusion 




Figure 11. Complex viscosity |ƞ*| for formulations F1 – PEG 0 % (T= 150°C), F2 – PEG 5 % 
(T= 130°C), F3 – PEG 10 % (T= 130°C) and F4 – PEG 15 % (T= 130°C). 
 
 
Figure 12. G’ (storage modulus) and G” (loss modulus) for formulations: F1 – PEG 0  %, F2 





In addition, tan  values of greater than one (Figure 13) suggested that the materials were 
more liquid-like and enhanced extrudability by improved viscous flow of the molten polymer 
in the extruder (Gupta et al., 2014). Smaller values of tan  for formulations F1 and F2 in 
Figure 13 indicated stronger microstructure of the polymer matrix.  On the other hand, at a 
higher angular frequency, an apparent plateau in G’ was observed in all formulations due to 
moisture, air bubbles or presence of multiphase in the system (Aho et al., 2016). This 
observation was verified in DSC thermograms where signs of crystalline PEG4000 were 
observed at the cooling cycle and broadening of Tg was observed when the samples were 
heated at the 2nd heating cycle for formulations F3 and F4 (Figure 15). On the other hand, 
formulations F1 and F2 did not show any peak broadening. Therefore, it further suggested 
that presence of air bubbles could be the cause of the apparent plateau for G’. However, two 
phases for formulations F3 and F4 could be brought about by the supersaturation of PEG in 
the system which may had contributed to the weaken microstructure of polymer systems.  
 
Figure 13. G’ (storage modulus) and tan () for formulations F1 (+PEG 0 %), F2 (+PEG 5 




Figure 14. DSC thermogram at first heating cycle (20°C /min) of pure PEG. 
 
 
Figure 15. DSC thermograms at first heating cycle (20°C /min) of pure CPV, formulations F1 
(+PEG 0 %), F2 (+PEG 5 %), F3 (+PEG 10 %) and F4 (+PEG 15 %). 
  
Melting peak of PEG 
F4 – PEG 15% 
F3 – PEG 10% 
F2 – PEG 5% 




4.1.2.1.2. Physicomechanical properties 
 
Mechanical properties of polymer extrudates are affected by structural factors such as 
molecular orientation, plasticization and molecular weight, among others (Landel and 
Nielsen, 1993). Extrudate strands from each formulation were evaluated for their mechanical 
properties; hardness and brittleness. Appropriate speed was selected to ensure that sequence 
of events leading to fracture could be observed. Use of craft knife adaptor ensured hard 
samples can be sheared with precision and without compressing them. Force–distance curve 
(Figure 16) was used to evaluate hardness and brittleness. The peak force was considered as 
an indication of hardness of the sample and the distance (mm) at which the sample broke was 
taken as a measure of brittleness (Altan et al., 2008).  
 
 






Distance at peak force 
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When a trigger load of 5 g from texture analyzer was detected at surface of the sample, the 
probe (craft knife blade) proceeded to shear the sample. Increased in force was observed 
when the craft knife sheared through the exterior layer of extrudate strand. The peak force 
and the distance taken to achieve peak force were recorded as hardness and brittleness, 
respectively. Hardness indicates the ability of a material to resist scratching, abrasion, 
indentation or penetration and it taken as being directly proportional to tensile strength, for 
dimensionally similar samples. Brittleness indicates a property to breaking without much 
plastic distortion. Brittle materials break or fail before much deformation takes place (Anton 
and Subhash, 2000; Lawn and Marshall, 1979). Hardness of formulation F1 containing no 
PEG was higher than the other formulations containing PEG and it could be concluded that 
the hardness of the extrudates was reduced in the presence of the processing aid (Figure 17). 
An increase in PEG concentration did not show any significant impact on the hardness as 











































On the other hand, one-way analysis of variance (ANOVA) indicated significant differences 
in brittleness among formulations with different concentrations of PEG. Brittleness of all 
formulations were within the range of 1.05 to 1.25 mm. Additionally, formulations F1 and F2 
showed less variability in terms of brittleness, suggesting stronger microstructure of the 











































Figure 18. Brittleness of extrudate strands for formulations F1, F2, F3 and F4. 
 
Size distribution of pellets was determined by size analysis using sieves. The shape of the 
pellets was evaluated by using the 2D images obtained using a polarized light microscope 
with an attached camera. With an image analysis software, the digitized images generated 
shape factors of roundness (R) and aspects ratio (AR). Figure 19 shows the particle size and 
size distribution of the formulations with and without PEG as the processing aid. For all 
formulations, D10, D50 and D90 values were comparable. It could be perceived that at the point 
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of fractionation, mechanical impact from the fractionator’s blade insert onto the external 
surface of the extrudates strands and the similar breaks were produced due to the similarity of 
the strands’ brittleness (fracturability) values. The particle size distributions of the 
fractionated pellets were generally very narrow and calculated span values for all 
formulations were within the range of 0.29 to 0.35. This suggested that the use of the same 
backbone polymer could have resulted in products with similar particle size distributions 
(Bialleck and Rein, 2011). Thus, the findings indicated that CPV solid dispersion pellets 
could be produced within a narrow size distribution when using the fractionation technique 






F1 - PEG 0%
F2 - PEG 5%
F3 - PEG 10%














Figure 19. Pellets size parameters of D10, D50 and D90 for formulations F1, F2, F3 and F4 
before spheronization. 
 
Figure 20 shows the initial shape data of R and AR as a function of concentration of PEG and 
it was observed that both R and AR for all formulations were greater than one, and the 

















































































Figure 20. (A) Aspect ratio and (B) roundness of pellets before spheronization for 
formulations F1, F2, F3 and F4. 
 
The SEM photomicrographs in Figure 21 illustrate a cylindrical shape for the ends of the 
extrudates, for all formulations after fractionation. Relatively smooth surfaces were observed 
for all formulations. Observation of some hairline crack fractures on the external surfaces of 















Figure 21. SEM photomicrographs of pellets after fractionation (A) F1, (B) F2, (C) F3, and 
(D) F4. 
 
4.1.2.2.  Post- Spheronization Characteristics 
 
It has been reported that pellet size is determined by the screen diameter for pellets prepared 
by the wet extrusion spheronization approach (Wilson and Rough, 2007). However, impact of 
pellet size and size distribution on melt spheronization had yet to be evaluated. In wet 
spheronization, it was reported that spheronization speed impacted pellets properties (Vervaet 
et al., 1995). When the pellets were spheronized at room temperature and without further 
addition of liquid or solid binders, spheronization conditions such as disc rotational speed and 
duration could impact pellet size and size distribution. This observation was also seen in melt 
spheronization where pellet size and size distribution were impacted by the spheronization 
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speed when a significant amount of mechanical force was applied. Figure 22 and Figure 23 
show the plots of cumulative weight % undersize obtained from size analyses using sieves for 
formulations F1 to F4 at spheronization speeds of 1000 to 2500 rpm and spheronization 
durations of 15 to 60 min. Figure 22 and Figure 23 indicate that at lower spheronization 
speeds (< 2000 rpm), there were no significant changes in cumulative weight %  undersize 
plots although the pellets were spheronized for different durations, from 15 min to 60 min. 
When spheronization speed was increased to 2000 rpm and beyond, most of the formulations 
showed differences in cumulative weight % undersize plots, indicating changes in the size 
and size distribution of the products. It was also observed that the shape of the cumulative 
weight % undersize plots for all the formulations (F1 to F4) were relatively similar when they 
were spheronized from 15 min to 60 min at the respective spheronization speeds. Therefore, 
it was elucidated that the effect of spheronization durations had no major impact for all 


















F1 - PEG 0% - 1000 rpm 15 min
F1 - PEG 0% - 1000 rpm 30 min
F1 - PEG 0% - 1000 rpm 45 min

































F2 - PEG 5% - 1000 rpm 15 min
F2 - PEG 5% - 1000 rpm 30 min
F2 - PEG 5% - 1000 rpm 45 min






























F1 - PEG 0% - 1500 rpm 15 min
F1 - PEG 0% - 1500 rpm 30 min
F1 - PEG 0% - 1500 rpm 45 min

































F2 - PEG 5% - 1500 rpm 15 min
F2 - PEG 5% - 1500 rpm 30 min
F2 - PEG 5% - 1500 rpm 45 min






























F1 - PEG 0% - 2000 rpm 15 min
F1 - PEG 0% - 2000 rpm 30 min
F1 - PEG 0% - 2000 rpm 45 min

































F2 - PEG 5% - 2000 rpm 15 min
F2 - PEG 5% - 2000 rpm 30 min
F2 - PEG 5% - 2000 rpm 45 min




















 (A-4)  












F1 - PEG 0% - 2500 rpm 15 min
F1 - PEG 0% - 2500 rpm 30 min
F1 - PEG 0% - 2500 rpm 45 min

































F2 - PEG 5% - 2500 rpm 15 min
F2 - PEG 5% - 2500 rpm 30 min
F2 - PEG 5% - 2500 rpm 45 min




















Figure 22. Cumulative weight % undersize plots for (A-1) F1, 1000 rpm (15-60 min), (A-2) 
F1, 1500 rpm (15-60 min), (A-3) F1, 2000 rpm (15-60 min), (A-4) F1, 2500 rpm (15-60 min), 
(B-1) F2, 1000 rpm (15-60 min), (B-2) F2, 1500 rpm (15-60 min), (B-3) F2, 2000 rpm (15-60 

















F3 - PEG 10% - 1000 rpm 15 min
F3 - PEG 10% - 1000 rpm 30 min
F3 - PEG 10% - 1000 rpm 45 min

































F4 - PEG 15% - 1000 rpm 15 min
F4 - PEG 15% - 1000 rpm 30 min
F4 - PEG 15% - 1000 rpm 45 min

































F3 - PEG 10% - 1500 rpm 15 min
F3 - PEG 10% - 1500 rpm 30 min
F3 - PEG 10% - 1500 rpm 45 min

































F4 - PEG 15% - 1500 rpm 15 min
F4 - PEG 15% - 1500 rpm 30 min
F4 - PEG 15% - 1500 rpm 45 min


































F3 - PEG 10% - 2000 rpm 15 min
F3 - PEG 10% - 2000 rpm 30 min
F3 - PEG 10% - 2000 rpm 45 min

































F4 - PEG 15% - 2000 rpm 15 min
F4 - PEG 15% - 2000 rpm 30 min
F4 - PEG 15% - 2000 rpm 45 min

































F3 - PEG 10% - 2000 rpm 15 min
F3 - PEG 10% - 2000 rpm 30 min
F3 - PEG 10% - 2000 rpm 45 min

















 (D-4)  












F4 - PEG 15% - 2500 rpm 15 min
F4 - PEG 15% - 2500 rpm 30 min
F4 - PEG 15% - 2500 rpm 45 min

















 Figure 23. Cumulative weight % undersize plots for (C-1) F3, 1000 rpm (15-60 min), (C-2) 
F3, 1500 rpm (15-60 min), (C-3) F3, 2000 rpm (15-60 min), (C-4) F3, 2500 rpm (15-60 min), 
(D-1) F4, 1000 rpm (15-60 min), (D-2) F4, 1500 rpm (15-60 min), (D-3) F4, 2000 rpm (15-




 shows the overview of experimental responses with respect to independent factors 
(formulation, spheronization speed and spheronization duration). The fines (< 0.5 mm) 
generated by breakage during spheronization were not reported.  The experimental data 
revealed that the particle size distributions of pellets for all formulations were very narrow 
and usually, span values of below 0.5 were obtained for spheronization speeds of 1000 to 
2000 rpm. The spheronization duration did not have any significant impact on span (Table 4). 
The span value of the pellets was wider (> 0.6) when they were spheronized at 2500 rpm.  
The particle size and span showed little or no change when the concentration of PEG was 
increased. D50 values of pellets of formulations F1 to F4 were similar when they were 
processed using the same spheronization conditions.  When the spheronization speed was 
increased, D50 of the pellets decreased slightly, indicating attrition or breakage of the pellets 
due to the higher mechanical forces applied. In addition, it was also observed that the 
concentration of PEG had little to no impact on the size and size distribution of the 
spheronized pellets. It was postulated that spheronization speed was primary factor 





Table 4. Overview of physical properties pellets at different spheronization conditions. Data 
represent mean values (± SD*) with n = 50 (R and AR) 
Expt code** D50 (µm) Span Ye% Roundness (R) Aspect ratio (AR) 
F1-1000-15 1125 0.42 67.60 1.34 (± 0.09) 1.73 (±0.30) 
F1-1000-30 1150 0.33 47.57 1.33 (± 0.10) 1.80 (±0.33) 
F1-1000-45 1150 0.34 46.00 1.28 (± 0.11) 1.70 (± 0.33) 
F1-1000-60 1150 0.35 46.44 1.26 (± 0.09) 1.55 (± 0.33) 
F1-1500-15 1150 0.35 66.51 1.29 (± 0.10) 1.68 (± 0.36) 
F1-1500-30 1150 0.33 59.41 1.26 (± 0.08) 1.59 (± 0.32) 
F1-1500-45 1135 0.38 57.72 1.25 (± 0.07) 1.72 (± 0.27) 
F1-1500-60 1135 0.38 56.87 1.23 (± 0.08) 1.65 (± 0.27) 
F1-2000-15 950 0.55 59.77 1.25 (± 0.09) 1.64 (± 0.25) 
F1-2000-30 950 0.50 49.47 1.22 (± 0.15) 1.51 (± 0.25) 
F1-2000-45 925 0.51 48.12 1.20 (± 0.09) 1.45 (± 0.24) 
F1-2000-60 925 0.51 39.66 1.21 (± 0.12) 1.37 (± 0.21) 
F1-2500-15 725 0.66 41.33 1.26 (± 0.08) 1.42 (± 0.20) 
F1-2500-30 750 0.60 30.31 1.20 (± 0.07) 1.34 (± 0.22) 
F1-2500-45 730 0.65 19.15 1.21 (± 0.08) 1.31 (± 0.21) 
F1-2500-60 680 0.54 17.45 1.21 (± 0.09) 1.27 (± 0.21) 
F2-1000-15 1125 0.47 91.88 1.34 (± 0.09) 1.74 (± 0.34) 
F2-1000-30 1140 0.42 65.02 1.30 (± 0.10) 1.81 (± 0.35) 
F2-1000-45 1145 0.38 50.73 1.30 (± 0.09) 1.83 (± 0.35) 
F2-1000-60 1150 0.38 36.09 1.31 (± 0.09) 1.73 (± 0.35) 
F2-1500-15 1150 0.33 91.08 1.28 (± 0.17) 1.93 (± 0.55) 
F2-1500-30 1150 0.37 75.00 1.35 (± 0.20) 1.88 (± 0.36) 
F2-1500-45 1130 0.31 60.35 1.35 (± 0.13) 1.78 (± 0.43) 
F2-1500-60 1160 0.31 45.21 1.28 (± 0.14) 1.76 (± 0.51) 
F2-2000-15 1090 0.41 71.30 1.29 (± 0.12) 1.45 (± 0.45) 
F2-2000-30 1090 0.42 56.45 1.23 (± 0.07) 1.61 (± 0.37) 
F2-2000-45 1075 0.42 43.56 1.21 (± 0.11) 1.55 (± 0.39) 
F2-2000-60 1025 0.46 28.32 1.24 (± 0.12) 1.65 (± 0.51) 
F2-2500-15 935 0.53 49.63 1.27 (± 0.21) 1.52 (± 0.30) 
F2-2500-30 860 0.57 34.50 1.23 (± 0.07) 1.57 (± 0.27) 
F2-2500-45 850 0.49 20.12 1.18 (± 0.06) 1.60 (± 0.29) 
F2-2500-60 800 0.53 6.59 1.18 (± 0.06) 1.51 (± 0.26) 
F3-1000-15 1150 0.48 92.31 1.35 (± 0.09) 1.89 (± 0.35) 
F3-1000-30 1175 0.31 63.60 1.32 (± 0.11) 1.71 (± 0.25) 
F3-1000-45 1175 0.31 46.83 1.29 (± 0.12) 1.75 (± 0.35) 
F3-1000-60 1190 0.31 32.63 1.28 (± 0.14) 1.80 (± 0.43) 
F3-1500-15 1125 0.47 90.44 1.36 (± 0.14) 2.09 (± 0.47) 
F3-1500-30 1135 0.37 70.15 1.33 (± 0.11) 1.96 (± 0.36) 
F3-1500-45 1150 0.35 50.40 1.27 (± 0.14) 1.79 (± 0.51) 
F3-1500-60 1155 0.33 37.61 1.26 (± 0.14) 1.70 (± 0.42) 
F3-2000-15 1025 0.49 61.69 1.27 (± 0.10) 1.74 (± 0.36) 
F3-2000-30 950 0.45 41.22 1.19 (± 0.06) 1.57 (± 0.25) 
F3-2000-45 910 0.47 25.85 1.16 (± 0.05) 1.48 (± 0.23) 
F3-2000-60 925 0.46 13.77 1.13 (± 0.03) 1.42 (± 0.18) 
F3-2500-15 735 0.68 61.10 1.19 (± 0.06) 1.46 (± 0.21) 
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F3-2500-30 750 0.70 31.24 1.17 (± 0.07) 1.38 (± 0.23) 
F3-2500-45 700 0.60 11.98 1.12 (± 0.03) 1.26 (± 0.11) 
F3-2500-60 650 0.43 5.13 1.17 (± 0.13) 1.25 (± 0.14) 
F4-1000-15 1175 0.29 92.38 1.34 (± 0.09) 1.62 (± 0.30) 
F4-1000-30 1150 0.30 59.75 1.31 (± 0.12) 1.76 (± 0.37) 
F4-1000-45 1175 0.30 45.13 1.24 (± 0.04) 1.63 (± 0.21) 
F4-1000-60 1175 0.29 31.97 1.24 (± 0.07) 1.70 (± 0.27) 
F4-1500-15 1160 0.29 69.27 1.28 (± 0.06) 1.85 (± 0.21) 
F4-1500-30 1150 0.31 53.11 1.23 (± 0.11) 1.75 (± 0.33) 
F4-1500-45 1145 0.35 39.02 1.19 (± 0.07) 1.70 (± 0.33) 
F4-1500-60 1120 0.38 25.29 1.16 (± 0.07) 1.68 (± 0.32) 
F4-2000-15 1075 0.41 49.13 1.20 (± 0.06) 1.70 (± 0.31) 
F4-2000-30 925 0.38 30.65 1.18 (± 0.07) 1.69 (± 0.29) 
F4-2000-45 900 0.29 16.92 1.13 (± 0.05) 1.49 (± 0.24) 
F4-2000-60 890 0.37 3.61 1.17 (± 0.06) 1.39 (± 0.18) 
F4-2500-15 850 0.53 26.78 1.21 (± 0.06) 1.56 (± 0.26) 
F4-2500-30 700 0.61 14.22 1.23 (± 0.13) 1.41 (± 0.22) 
F4-2500-45 675 0.56 3.63 1.17 (± 0.05) 1.33 (± 0.17) 
F4-2500-60 675 0.81 4.20 1.12 (± 0.04) 1.25 (± 0.13) 
* SD = standard deviation 
** Expt code: FX-YYYY-ZZ where FX represents formulation type, YYYY represents 
spheronization speed (rpm) and ZZ represents spheronization duration (min) 
Values in parentheses represent standard deviations. 
 
In addition to size and size distribution, process efficiency determined by the product yield 
defined by a specific fraction of useful pellets was important. For this study, pellets sizes 
within 0.5 mm to 1.8 mm were considered useful and considered as the effective yield (Ye%). 
During spheronization, pellets were mechanically impacted by high shear forces from the 
protuberances on the fractional plate. Breakages or attritions and subsequent rounding of 
cylindrical pellets during spheronization were random processes and collisions between 
pellets and pellets against the wall of the spheronizer were additional impacts that could 
further caused abrasion and rounding of the pellets. As a result, the Ye% and the shape of the 
pellets were considered to be influenced by the mechanical and rheological properties of the 
formulations together with the shape of the pellets prior to spheronization. 
Figure 24 suggests that with an increase in spheronization speed and duration, there was a 
decrease in Ye%. Formulations with PEG appeared to have a lower Ye% compare to the 
64 
 
formulation without PEG.  When the concentration for PEG was increased, Ye% decreased 
and it was postulated that the lower the hardness of the extrudates, the lesser the Ye% due to 
poorer mechanical strength of the extrudates. Less than 10 % effective yield was obtained for 
formulations with PEG when they were spheronized at 2500 rpm. In terms of R and AR, 
changes from initial shape were not noticeable at lower spheronization speed and duration. 
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Figure 24. Ye% for F1, F2, F3 and F4 pellets spheronized at (A) 1000 rpm (15-60 min), (B) 




4.1.3. Statistical analysis  
 
Main effects plots of R and AR are presented in Figure 25 and Figure 26. It was observed that 
all the independent factors (concentration of PEG, spheronization speed and spheronization 
duration) had significant effects on roundness and aspect ratio values. Both roundness and 
aspect ratio value decreased when the concentration of PEG was increased. This suggested 
that when PEG concentration increased, the elastic property (G’) increased and material 
became more solid-like, exhibiting more marked elastic properties which allowed shape 
change and rounding without any significant fragmentation by the increase in the mechanical 
strength of the pellets.  Similarly, it was also observed that R and AR decreased, became 
closer to one, when the spheronization speed and duration were increased.  
 
 
Figure 25. Main effects plots for PEG concentration (P<0.001*), spheronization speed 





Figure 26. Main effects plots for PEG concentration (P<0.001*), spheronization speed 
(P<0.001*), and spheronization duration (P<0.001*) on aspect ratio (AR) (*denotes 
statistically significant effects). 
 
4.1.4. Proposed mechanism of pellets’ shapes evolution with respect to spheronization 
speed and time 
 
In wet spheronization, extrudates were fractured across their lengths by shear forces from the 
rotating frictional plate surface, along with small continual collisions with the protuberances 
on the frictional plate, with other extrudates or between extrudates and container wall (Liew 
et al., 2007). The formation or rounding of pellets’ shape could also be influenced by 
breakages. The most commonly reported breakage mechanisms in  literature are   







Fragmentation is the process in which the 
original pellet breaks into relatively large 
fragments. In pelletization, breakage occurs 
when a large pellet breaks into a few 
fragments. 
Shattering  Shattering is the process of total breakage of 
the original pellet into small particles without 
leaving any large fragments  
Abrasion  
 
Abrasion (also called attrition) is the process 
in which the outer shell of the pellet wears 
down at the surface. This results in one large 
pellet and a number of very little particles. 
Figure 27. Mechanisms of pellets breakage.  
 
The criterion for successful spheronization is that the extrudates must be able to break up into 
regular sized fragments and the fragments are sufficiently plastic to be rounded by the 
frictional forces supplied by collisions, with the rotating frictional plate, other pellets and the 
spheronizer wall (Conine and Hadley, 1970). Several phenomenological models have been 
reported in literature for wet spheronization process. Rowe (1985) reported that cylindrical 
extrudates broke into shorter lengths which collided with each other, the friction plate and the 
walls. The rods underwent plastic deformation which transformed them to become rounded 
cylinders. These cylinders are subsequently rounded to dumbbells, then to ellipsoid or egg 
shaped studs and finally into spheroids (Harrison et al., 1985). Baert et al. (1993) also 
suggested that rods are rounded by collisions with the walls and other pellets and become 
twisted, eventually breaking into daughter pellets which are round and with fractured sides. 
The latter faces are folded together by the rotating and frictional forces on the friction plate to 
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form the near spherical pellets. This folding action was claimed to explain why some pellets 
contain a cavity (Baert and Remon, 1993).  Liew et al. (2007) studied the effect of extrusion 
on extrusion-spheronization and observed in their spheronization runs, pellets pass through 
the dumbbell stage and become spherical by agglomeration of fines in the mid plane or 
‘waist’ region of the pellet. 
The rounding mechanism of pellet shape by the melt spheronization process could be 
demonstrated by image analysis of pellets from the 0.8 – 1.0 mm weight fraction collected 
after the application of various spheronization speeds and durations. The images of the pellets 
were captured using a camera mounted on a microscope and viewed under the polarized light. 
The images were then converted into binary color images for clear visualization. Based on the 
physicomechanical data (Table 4) and pictorial illustrations, it was stipulated that 
fragmentation of large particles and abrasion of pellets into fines were two major rounding 
principles of melt pellets. A significant loss in mass of was observed when the spheronization 
speed and duration were increased. Similar observation was also reported for solid lipid 
spheronization process (Reitz and Kleinebudde, 2009). During the spheronization process, it 
was noticed that the weight fraction of the desired particle size range of pellets was decreased 
when the spheronization speed and time were increased. The observation in the decreased 
weight fraction inferred that the rounding process of the pellets had caused fragmentation and 
the generation of fines.  In addition, edges and surface irregularities of the pellets underwent 
attritions and yielding fines. Evolution of rounded pellets by the spheronization speed and 
duration was visualized from the pictures in Figure 28. Roundness (R) and aspect ratio (AR) 
values from Table 4 also suggested that the shapes of the pellets were closer to spherical 
when spheronization speed and duration was increased. The similar observation was also 
reported that the histograms of AR and circularity increase with time and converging towards 



































2000 rpm – 60 min 
 
     
1500 rpm – 15 min 
 
 
1500 rpm – 30 min 
 
 
1500 rpm – 45 min 
 
 
1500 rpm – 60 min 
 
 
1000 rpm – 15 min 
 
 
1000 rpm – 30 min 
 
 
1000 rpm – 45 min 
 
    
1000 rpm – 60 min 
  
Figure 28. Pictorial illustration of pellets rounding steps with respect to spheronization speed 
and duration. 
 
Based on the observation above, the melt pellets rounding mechanism could be described as 
follows: 
 Attrition of corners and edges of pellets that caused rounding process at low shear 
force with shorter duration.  
 Fragmentation of pellets into smaller particles was observed when the spheronization 
run began at a high shear force. Rounding effects could be continued when wither 




































 Shattering of larger pellets into smaller particles occurred when the spheronization 
run was initiated at very higher rotational speeds. Particles were rounded after 
shattering due to continuous rotating movements. 
 
 
                                                                                  
                   Attrition                              further rounding      
 
 
                                                                                     
               Fragmentation                      further rounding 
 
 
                                                                                          
              Shattering                                               further rounding 
 
Figure 29. Schematic model of pellet rounding during spheronization.  
.  
Low shear force Low shear force 
High  shear force High / Low  shear force 





CPV-PEG solid dispersion multiparticulates (pellets) were developed using melt 
spheronization approach. A full factorial DOE was applied to investigate the influence of the 
concentration of PEG 4000, spheronization speed and run duration and their effect on size, 
size distribution and shape of CPV-PEG pellets. Physicomechanical properties of pellets were 
evaluated before and after spheronization.  Increasing of PEG concentration did not appeared 
to significantly impact the hardness of the extrudates. However, there were significant 
differences in brittleness when the PEG concentration was increased. The particle size 
distributions of the fractionated pellets were generally very narrow and had span values of 
ranging from 0.29 to 0.35. Evaluation results indicated that spheronization speed was the 
primary factor contributing to pellet breakage and affecting the size distribution of the 
spheronized pellets. In contrast, spheronization duration did not produce any significant 
impact. In addition, when spheronization speed and duration were increased, there was a 
decrease in Ye% and formulations with PEG had lower Ye% values compared to the 
formulation without PEG. On the other hand, R and AR were decreased (became more 
spherical) when the spheronization speed and duration were increased. Similarly, both R and 
AR decreased when the concentration of PEG increased. In summary, thus far, this study 
demonstrated that highly spherical CPV-PEG pellets could be produced by melt 
spheronization. Spheronization speed had a major impact on the size, size distribution and 
Ye% of the pellets and concentration of PEG could affect R and AR positively. In addition, 
based on the observation in the study, a mechanism for the pellets to achieve a spherical 
shape with respect to spheronization speed and time was proposed.  
72 
 
4.2. Study B. Incorporation of a meltable drug, IBU and its impact on physicochemical 
properties of pellets in melt spheronization 
4.2.1. Rational for selection of IBU 
 
Plasticization of a polymer modifies the mechanical properties of the polymeric system. 
Many reports have concluded that the efficiency of a plasticizer was in correlation with 
chemical structure and its interaction between functional groups and a polymer. The influence 
of different types of plasticizers on the mechanical properties of meltable polymers are 
therefore important to be evaluated.   
In section 4.1 (Study A), incorporation of PEG as a hydrophilic plasticizer was studied. 
Increasing concentration of PEG had lowered Tg and melt viscosity of the polymeric system 
which enhanced the extrusion process by lowering operational temperatures. It was also 
suggested that the concentration of PEG had a positive impact on pellets’ shape, by 
decreasing R and AR. However, less desirable influences on size and size distribution of 
pellets were observed when PEG concentration was increased.  
In this study (section 4.2), use of hydrophobic plasticizer as a processing aid on the impact of 
melt spheronization was evaluated. Hydrophobic plasticizers such as triethyl citrate and 
acetyltributyl citrate were used in development of thin, flexible and opaque HPC films and 
the influence of these plasticizers on the physicochemical properties of the films had been 
investigated (Repka et al., 2008).  (Repka et al., 2008).  Similarly, plasticizing effects of 
hydrophobic drugs were reported by many studies and IBU was one of the widely reported 
drug in many literature reports (De Brabander et al., 2002; Kidokoro et al., 2001; Özgüney et 
al., 2009; Wu and McGinity, 1999). Plasticizing properties of IBU on the impacts of 
physicomechanical properties were determined when IBU was used as a meltable drug 
incorporated. IBU was reported to have a plasticizing effect on acrylate polymers when the 
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films were prepared from aqueous colloidal polymer dispersions (Wu and McGinity, 1999). 
Thus, the incorporation of the drug IBU as an unconventional plasticizer and its impact on 
physicochemical properties of pellets in melt spheronization are yet to be investigated.  
IBU is a phenyl propionic acid derivative in crystalline form and is poorly soluble in water. It 
is widely accepted as one of the best tolerated nonsteroidal anti-inflammatory drug and was 
the first phenyl alkanoic acid approved by the US FDA for general analgesic use. The most 
frequent adverse effects associated with IBU include peptic ulceration and gastrointestinal 
disturbances such as bleeding (Britain, 1941). In addition, IBU is classified as class II drug 
which indicated that dissolution is the rate-limiting step for the drug to be absorbed after 
ingestion as according to the Biopharmaceutics Classification System. Therefore, 
development of pellets containing IBU as a multiparticulate dosage form could offer not only 
therapeutic advantages but also be less of an irritant to the gastrointestinal tract. In this 
current study, IBU (Figure 30) with molecular weight of 206.28 was the meltable drug 
incorporated and its possible plasticizing properties evaluated in the melt spheronization 
process. 
 




4.2.2. Evaluation on miscibility of different concentrations of IBU for melt spheronization 
 
Miscibility of IBU blends were determined by DSC and the Tg values of the blends were 
estimated from DSC thermograms. Physical blends of 10, 20 and 30 % (w/w) IBU with CPV 
were prepared for thermal and rheological analyses. Figure 31 shows thermograms of pure 
IBU at the first heating circle and the binary blends at the second heating cycle. The first 
heating cycle was performed to yield a fused blend of the drug and polymer, thus mimicking 
the phase transitions that would occur in an extruder. The molten blend was then cooled and 
reheated to test for residual drug crystallinity as measured by residual melting enthalpy peaks. 
It was observed that the pure IBU had a melting temperature (Tm) at approximately 79.86°C 
and there was no observable melting peak of IBU for physical blends at the second heating 
cycle, suggesting that IBU became a melt solution in the polymer matrix. The IBU-CPV solid 
dispersion system exhibited a single Tg value and Tg values for the blends were from 23.96 to 
53.00 ˚C (Figure 31) indicating that IBU exerted as a plasticizing effect which had resulted in 
weakening the intermolecular attractions in CPV and increased its free volume. Hence, CPV 
molecules moved more freely and causing an increase in their mobility and flexibility. Thus, 
the objective of study B was to evaluate the use of a meltable drug, IBU, for its potential to 
act as a hydrophobic plasticizer in melt spheronization. The effects of IBU, in amounts of 10-





Figure 31. DSC thermograms of pure IBU and 10% - 30% IBU blends. 
  
Pure IBU 
10% (w/w) IBU 
20% (w/w) IBU 
30% (w/w) IBU 
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4.2.3. Evaluation on processibility of different concentrations of IBU for melt 
spheronization 
 
Rheological behavior of formulation components determines the ability to extrude and this is 
mainly influenced by properties of the components in the formulations. In general, the 
extrudate viscosity was found to be highly temperature dependent but the temperature used 
for extrusion should not approach the degradation temperature of the drug or other constituent 
components. On the other hand, high viscosity formulations can cause excessively high 
torque level and a long residence time in the extruder which together may lead to product 
degradation (Lyons et al., 2007). Extrudability of IBU-CPV powder blends were evaluated 
using 25-mm parallel plates with a gap distance of 0.5 – 0.6 mm in oscillation mode and their 
rheological properties recorded. Dynamic temperature ramp was conducted at a constant 
frequency of 1 Hz (6.28 rad/s) at controlled strain amplitude of 0.05 %. The test temperature 
was set at 90°C prior to adding the test material and the run was commenced when the test 
material had achieved an equilibrium temperature. The measurement temperature ranged 
being evaluated was from 90 to 150°C. All measurements were conducted in duplicate. 
Figure 32 shows that all three physical mixtures of IBU had higher G” values and indicating 
that all the IBU-CPV blends showed more liquid-like behavior. There was no crossover point 
observed within the test temperature range and therefore, the powder blends had relatively 
less elastic properties. The complex viscosity of each powder blend was found to follow a 
shear-thinning behavior which was typical of many polymer melts and its viscosity decreased 
when temperature increased. The softening temperature of all the blends were above 120°C 
and 10 % (w/w) IBU blend showed lowest tan (), suggesting that it was the least liquid-like 











Figure 32. Complex viscosity, |ƞ*| (__); Storage modulus, G’ (__); Loss modulus, G” (__) ; 
and Damping factor, tan (δ) (__) of (A) 10% (w/w) IBU blend, (B) 20% (w/w) IBU blend,  
and (C) 30% (w/w) IBU blend at temperature sweep test between 90 to 150°C. 
 
Feasibility runs were performed to evaluate processibility of the powder blends using 
extrusion temperatures from 110˚C to 150˚C. Extrudability values of the powder blends were 
summarized in Table 5. For 10 % (w/w) IBU blend, 120°C to 150°C extrusion temperatures 
were used and high torque values were observed for extrusion temperatures up to 140°C. 
However, at 150°C, brownish colored extrudates were obtained, indicating that thermal 
degradation of IBU at the higher extrusion temperature had occurred and this was also 
explained by TGA analysis (Figure 33) where IBU was stable up to 128°C and presented a 
single stage of mass loss between 128°C and 218°C (m ~ 98 %). Therefore, it was 
concluded that extrudability of 10 % (w/w) IBU was not feasible to be melt spheronized and 
further characterized. On the other hand, both 20 % and 30 % (w/w) IBU blends were 
feasible to be extruded, except that at 130°C, melt extrudates from 30 % (w/w) IBU blends 
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were too fluid to be fractionated and sized. Therefore, extrusion temperature for both 
formulations was set at 120°C as per the feasibility on the processibility and product stability. 
Both formulations were also used for further experiments. 
 









10 % (w/w) 
IBU 
120 > 20* No extrudate obtained due to high torque 
130 > 20* No extrudate obtained due to high torque 
140 > 20* No extrudate obtained due to high torque 
150 11.0 Brownish extrudates obtained. 
20 % (w/w) 
IBU 
110 15.7 Clear extrudates obtained. 
120 10.3 Clear extrudates obtained. 
130 5.0 
Clear extrudates obtained. 
30 % (w/w) 
IBU 
110 14.0 Clear extrudates obtained. 
120 8.2 Clear extrudates obtained. 
130 3.5 Clear extrudates obtained. Extrudates were too 
fluid and unable to be fractionated and sized. 




Figure 33. TGA curve of pure IBU.  
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4.2.4. Development and characterization of IBU pellets using design of experiment (DOE) 
 
Investigations on the influence of 20 % and 30 % IBU in CPV-PEG pellet formulations on 
the physicochemical properties of the pellets produced were made by evaluating the impact of 
spheronization speed and duration. Overview of the experimental design used is presented in 
Table 6 and factorial design of the experiment is listed in Table 7. Temperature profiles and 
extrusion conditions used in study B are mentioned in Table 1. After extrusion and 
fractionation, extruded strands and pellets were characterized for shape, size and size 
distribution. 
 
Table 6. Study B: Experimental overview. 
Factors Levels used 
% IBU 20 30  
Spheronization speed (RPM) 1000 2000 3000 















1 20-1000-15 1000 15 
2 20-1000-30 1000 30 
3 20-1000-60 1000 60 
4 20-2000-15 2000 15 
5 20-2000-30 2000 30 
6 20-2000-60 2000 60 
7 20-3000-15 3000 15 
8 20-3000-30 3000 30 
9 20-3000-60 3000 60 
10 30-1000-15 1000 15 
11 30-1000-30 1000 30 
12 30-1000-60 1000 60 
13 30-2000-15 2000 15 
14 30-2000-30 2000 30 
15 30-2000-60 2000 60 
16 30-3000-15 3000 15 
17 30-3000-30 3000 30 




4.2.5. Evaluating of physicomechanical properties 
4.2.5.1.  Extruded Strands 
 
Mechanical properties of extruded strands from 20 % and 30 % (w/w) IBU formulations were 
evaluated. Extruded strands from each formulation were characterized for their hardness and 
brittleness but no statistical differences were obtained for the two formulations. As hardness 
and brittleness are attributed associated with the mechanical properties, both formulations 
were deemed to be similar in their mechanical strength. As the mechanical properties of 
polymeric extrudates are influenced by the polymer structural, molecular weight and 
plasticization effects (Landel and Nielsen, 1993), it was inferred that the concentration of 
IBU, at 30 % or less, did not have a significant impact on the mechanical properties of the 
melt extrudates. It could be explained that the lower molecular weight of IBU had little 



















































Figure 34. Hardness of extruded strands for 20 % and 30 % IBU formulations.  
83 
 
4.2.5.2.  Fractionated Pellets 
 
After extrusion and fractionation, pellets were tested for their thermal response using DSC. 
The DSC thermograms (Figure 35) shows that both 20 % and 30 % IBU pellets had single Tg 
and the value of Tg for 20 % IBU extrudate was 54.33°C and that for 30 % IBU pellets was 
34.41°C. No observable IBU melting peak was seen and this suggested that IBU had formed 
a solid solution in the polymer matrix.  
 
 
Figure 35. DSC thermograms of 20 % and 30 % IBU pellets. 
 
Results from DSC analysis was supported by XRD measurements where the characteristic 
IBU peaks were absent from the diffractograms for both 20 % and 30 % IBU pellets 
formulations (Figure 36). In addition, XRD profiles exhibited broad amorphous ‘halo peaks’ 
indicating that IBU-CPV pellets formed amorphous solid dispersion.  
20% IBU pellets 




Figure 36. XRD profiles of 20% and 30% IBU pellets. 
 
Particle size and size distribution of 20 % and 30 % IBU pellets prior spheronization were 
characterized using size analysis using sieves. Figure 37 shows D50 and span of both 
formulations where D50 for 20 % IBU pellets was 1075 m and that for 30 % IBU was 1200 
m. The differences in D50 values were statistically insignificant.  Span of 20 % IBU 
formulation was 0.6 and that of 30 % IBU was 0.39, indicating that the pre-spheronization 































Figure 37. Pellets size D50 and size distribution (Span) of 20% and 30% IBU pellets before 
spheronization. 
 
20% IBU pellets 




Similarly, initial shape factors of pellets were characterized and found not to be statistically 






















































Figure 38. Roundness and aspect ratio of 20 % and 30 % IBU pellets pre-spheronization. 
 
4.2.5.3.  Spheronized Pellets 
 
Fractionated pellets were spheronized according to spheronization conditions described in 
Table 7 and the spheronization temperature of all experiments was maintained at 25°C, a 
temperature below the Tg of both formulations. The rationale behind setting the 
spheronization temperature below the Tg of the formulations was in consideration to the 
amorphous properties of IBU-CPV formulations. The low processing temperature ensured 
that the process did not provide thermal energy to exceed the energy barrier required to cause 
the solid solution to crystallize out the IBU dissolved within the polymeric matrix. During the 
spheronization, it was observed that formulation with 30 % IBU adhered on the side surface 
of the spheronizer bowl and swirling motion of the pellets was considerably less obvious. 
Moisture uptake by the pellets was monitored using a moisture tester and the % LOD 
measurements were made to compare pellets pre and post spheronization. No observable 
moisture uptake was seen for both 20 % and 30 % IBU formulations in pellets prepared using 
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different spheronization conditions. However, at the end of each spheronization run, pellets 
had to be scraped from the side of the bowl for all 30 % IBU formulations. D50, Ye%, R and 
AR of the pellets were assessed after spheronization, and summary of the results is tabulated 
in Table 8.  
 
Table 8. Overview of physical properties pellets at different spheronization conditions. Data 





Span Ye% Roundness (R) Aspect ratio 
(AR) 
1 20-1000-15 1125 0.60 92.32 1.2961 (±0.13) 1.2127 (±0.14) 
2 20-1000-30 1060 0.61 91.99 1.2555 (±0.08) 1.3053 (±0.20) 
3 20-1000-60 1200 0.38 91.13 1.2579 (±0.11) 1.3329 (±0.24) 
4 20-2000-15 900 0.56 74.01 1.1312 (±0.05) 1.1780 (±0.15) 
5 20-2000-30 860 0.52 71.29 1.1425 (±0.08) 1.1702 (±0.16) 
6 20-2000-60 875 0.34 42.24 1.1995 (±0.10) 1.1499 (±0.15) 
7 20-3000-15 550 0.77 3.47 1.1617 (±0.06) 1.2328 (±0.15) 
8 20-3000-30 650 1.31 3.33 1.1494 (±0.11) 1.1812 (±0.33) 
9 20-3000-60 100* 10.00* 1.77 1.1593 (±0.11) 1.2407 (±0.13) 
10 30-1000-15 1250 0.56 92.90 1.2001 (±0.06) 1.2890 (±0.18) 
11 30-1000-30 1275 0.71 95.30 1.1491 (±0.05) 1.3143 (±0.19) 
12 30-1000-60 1250 0.62 95.20 1.1632 (±0.04) 1.2367 (±0.14) 
13 30-2000-15 1150 0.87 66.20 1.1319 (±0.03) 1.2588 (±0.15) 
14 30-2000-30 950 0.61 45.30 1.1181 (±0.04) 1.2935 (±0.18) 
15 30-2000-60 950 0.79 39.70 1.1031 (±0.02) 1.1644 (±0.11) 
16 30-3000-15 675 0.74 21.20 1.0727 (±0.02) 1.1298 (±0.07) 
17 30-3000-30 650 0.42 16.17 1.1576 (±0.12) 1.1318 (±0.09) 
18 30-3000-60 675 0.74 19.60 1.1283 (±0.07) 1.1395 (±0.08) 
* Extrapolated values 
 
At a spheronization speed of 1000 rpm, there was little or no impact on size and size 
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distribution when compared to pellet attributes before spheronization (Figure 37).  When 
spheronization speed was further increased to 2000 rpm or 3000 rpm, the size of the pellets 
(D50) was decreased. It was apparent that frictional forces generated by the spinning motion 
of the frictional plate had caused collisions of pellets with the plate, between the pellets and 
also with the spheronizer wall.  However, for both 20 % and 30 % IBU formulations, no 
differences in D50 and size distribution were observed when the spheronization duration was 
varied (Figure 39 and Figure 40) when the spheronization speed was kept constant. Similar 
findings were also reported for piroxicam pellets prepared by the extrusion spheronization 
method (Sinha et al., 2007). Therefore, spheronization speed had a major impact on the 
product size when the spheronization speed was increased, the mean pellet size D50 
decreased. The span values of both formulations were less affected by spheronization speed 
and run duration but wider span was observed when the spheronization speed was increased 
to the maximum used, 3000 rpm, for pellets with 20 % IBU indicating that breakage of 
pellets had occurred due to the higher mechanical force presented. As for 30 % IBU, there 
was only minimal impact on the span of the pellets and it attributed to the high extent of 
pellets sticking onto the side of the bowl, thus, “protected” from the adverse conditions in the 
spheronization chamber. In terms of pellets shape, R and AR values of both formulations 
with 20 % and 30 % IBU were rather similar. When the spheroids were spun at a relatively 
low speed like 1000 rpm, the forces set up in the spheronizer appeared insufficient to round 
them up and the R and AR values were similar to that before spheronization (Figure 38). 
When higher spheronization speeds were applied, improvement in the rounding of pellets into 
spheroids became more apparent suggesting that the stronger rotational forces had 








































































































Figure 40. Cumulative % weight undersize of 30 % IBU pellets under different 
spheronization conditions. 
 
Likewise, Figure 41 indicates Ye% of both formulations decreased at higher spheronization 
speeds but spheronization duration had a lesser impact, compared to spheronization speed. At 
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1000 rpm, Ye% was not adversely affected even though the spheronization duration was 
increased from 15 to 60 min. However, at the maximum spheronization speed used, 3000 
rpm, Ye% was less than 3.5 % for 20 % IBU pellets and 21.2 % for 30 % IBU pellets. Ye% 
further decreased when the spheronization duration was prolonged. Hence, it could be 
concluded that the excessive forces applied at a very high spheronization speed was far too 
great and more fines were generated than the amount of effective yield. Ye% of pellets with 







































































4.2.5.4.  Statistical analysis on physical properties of IBU pellets 
 
Figure 42 shows the interaction effect of % IBU, spheronization speed and spheronization 
duration on Ye%  and based on regression analysis, statistically significant interaction effect 
was obtained for spheronization speed on Ye%. However, the interactions between % IBU 
and spheronization duration were statistically insignificant. Equation 12 (R
2
 = 93.61 %) 
summarizes the relationship between the % IBU, spheronization speed and spheronization 
duration on the Ye%. 
𝒀𝒆% =
𝟏𝟑𝟕. 𝟖 + 𝟎. 𝟐𝟐𝟐 (% 𝑰𝑩𝑼) − 𝟎. 𝟎𝟒𝟏𝟏 (𝒔𝒑𝒉𝒆𝒓𝒐𝒏𝒊𝒛𝒂𝒕𝒊𝒐𝒏 𝒔𝒑𝒆𝒆𝒅) −
𝟎. 𝟐𝟏𝟗 (𝒔𝒑𝒉𝒆𝒓𝒐𝒏𝒊𝒛𝒂𝒕𝒊𝒐𝒏 𝒅𝒖𝒓𝒂𝒕𝒊𝒐𝒏)                                                                                                         (12) 
 
 
Figure 42. Interaction plots of effect of % IBU (P = 0.645), spheronization speed (P < 





Similarly, Figure 43 provides the interaction effects of % IBU, spheronization speed and 
spheronization duration on D50 and based on regression analysis, statistically significant 
interaction effects were observed for % IBU and spheronization speed on D50. On the other 
hand, spheronization duration did not show any significant impact on D50.  Equation 13 (R
2
 = 
86.85 %) defines the relationship between the % IBU, spheronization speed and 
spheronization duration on the D50. 
𝐃𝟓𝟎 =




Figure 43. Interaction plots of effect of % IBU (P = 0.012*), spheronization speed (P < 




The main effect plots displayed similar trends with statistically significant effects of % IBU 
and spheronization speed on roundness, R. Mean roundness of 30 % IBU was closer to a 
sphere than that of 20 % IBU pellets. Similarly, at 2000 and 3000 rpm, the mean roundness 
was close to a perfect sphere, at R around 1.135 (Figure 44). The average roundness remained 
relatively constant, at around 1.16 to 1.17 when the spheronization duration was increased 
from 15 min to 60 min and the values were statistically insignificant. 
 
 
Figure 44. Main effect plots of % IBU (P = 0.018*), spheronization speed (P = 0.017*) and 
spheronization duration (P = 0.941) on roundness, R (*denotes statistically significant 
effects) 
 
Aspect ratio of pellets was significantly influenced by spheronization speed and Figure 45 
presents the effect of % IBU, spheronization speed and spheronization duration. Low AR 
values, < 1.18, were produced when the spheronization speed was increased to 3000 rpm. 
Less or no significant changes occurred when the % IBU and spheronization time were 
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increased. Therefore, it could be concluded that the potential of rounding effect in the 
spheronization process was mainly contributed by spheronization speed. 
 
 
Figure 45. Main effect plots of % IBU (P = 0.760), spheronization speed (P = 0.012*), and 






4.2.6. Solid states characterization of IBU pellets and impact of spheronization on its 
physicochemical properties 
 
After spheronization, pellets prepared using various spheronization conditions were 
characterized for size, size distribution and shape. Pellets after physical characterization were 
kept in airtight containers with a storage condition of 25°C for at least a day to allow for 
relaxation before commencing chemical or solid state characterizations. Although storage 
temperature was lower than Tg of 30 % IBU formulation, pellets were found to stick together 
and formed a layer of solid on storage and they could not be separated for further 
characterization (Figure 46).  
 
 Figure 46. Physical appearance and stability of 30% IBU pellets after spheronization. 
 
The lower Tg value of the solid dispersion system had resulted in a high degree of mobility 
and flexibility of molecules that had led to the decreased physical stability of the solid 
dispersion system. In order to achieve a kinetically stable 30 % IBU formulation, Zografi and 
co-workers suggested that such a formulation should be stored at least 50°C below Tg of the 
formulation, in order to achieve long-term physical stability (Hancock et al., 1995). 
Similar observation was also reported by Kyeremateng et al. (Kyeremateng et al., 2014)  for 
30-1000-15 30-1000-30 30-1000-60 30-2000-15 30-2000-30 30-2000-60 
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IBU with Soluplus polymer carrier system, where the formation of a thermodynamically 
stable solution at room temperature would not be feasible for a drug load greater than 35 wt 
%. Therefore, pellets samples containing 30 % IBU in the formulation were not included for 
chemical and solid state characterizations. 
 
4.2.6.1.  PLM and PXRD studies 
 
The polarized light microscopy (PLM) images of 20 % IBU pellets were shown in Figure 47 
(A) and (B).  All of the extruded pellets appeared to be transparent with glassy surfaces. To 
investigate the crystallinity in close-up, pellets were analyzed with and without crushing for 
both pre and post spheronization.  The image showed no observable residual drug crystals on 
the surface of the extruded pellet Similarly, Figure 48 indicates PXRD profile of pre and post 
spheronization of 20 % IBU pellets which were compared with that of pure IBU, CPV and 
physical blends. Although 20 % IBU physical blend showed crystalline IBU peaks, for 20 % 
IBU pellets, these crystalline peaks were not observed. In addition, broad amorphous halo 
peaks were observed for pellets spheronized under different conditions (1000-3000 rpm and 
15 – 60 min), suggesting that IBU-CPV pellets were still in amorphous solid dispersion form 





4.2.6.2.  Thermal analysis  
 
The observation from PLM and PXRD was supported by DSC thermograms where the pellets 
(Figure 49) with 20 % IBU consistently, despite differences in the spheronization conditions, 
had a single Tg value and no distinct IBU melting peak. Therefore, it was concluded that IBU 
was a solid dispersion in the polymer matrix. The higher mechanical forces applied during 








Figure 47. PLM image of 20 % IBU pellets (A) pre spheronization (uncrushed and crushed) 
and (B) post spheronization at 3000 rpm 60 min (uncrushed and crushed). 
 
Pre spheronization (uncrushed) 
Pre spheronization (crushed) 
Post spheronization (uncrushed) 








Figure 49. DSC thermograms of 20 % IBU physical blend, pellets pre spheronization and 
post spheronization pellets, spheronized at 3000 rpm for 60 min. 
 
20% IBU pellets – Spheronized  
at 3000 rpm for 60 min 
20% IBU pellets – Prior to 
spheronization 
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20% IBU physical blends 
20% IBU pellets prior to spheronization 














4.2.6.3.  FT-IR analysis  
 
To get a better understanding of the physical properties of the molecular dispersions, FT-IR 
analysis was performed.  The IR spectra of the pellets after spheronization are shown in 
Figure 50. They were overlaid with the IR spectra of pure IBU, pure CPV and 20 % IBU 
pellets before spheronization for comparison purposes. The FT-IR spectrum of pure IBU 
(Figure 50) showed an intense and sharp infrared band at around 1706 cm
-1
 (carbonyl-
stretching of isopropionic acid group) and multiple bands at 2800 - 3000 cm
-1
. In the FT-IR 
spectra of the 20 % IBU pellets, two distinctive carbonyl bands at 1660 and 1730 cm
-1
 are 
observed. These two bands are from the carrier polymer (CPV). The carbonyl band from the 
active is overlapped with the two carbonyl bands of CPV, and hence cannot be seen. It can be 
seen that the duration of spheronization had no impact on the carbonyl bands (wavenumber 
and intensity). 
 
Figure 50. FT-IR spectra of 20 % IBU pellets after spheronization at 3000 rpm and 60 min 
compared with 20 % IBU pellets prior to spheronization, 20 % IBU physical blend, pure CPV 
and pure IBU. 
Pure CPV 
Pure IBU 
20% IBU physical blend 
20% IBU pellets prior to spheronization 
20% IBU pellets after spheronization at 3000rpm and 60 min 
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As compared to the multiple bands at 2800 – 3000 cm-1 of pure IBU, these bands become 
broad in the spectra of all 20 % IBU pellets and CPV due to overlapped C–H stretching 
vibration from both the drug substance and the carrier polymer.  The FT-IR analysis 
confirmed that spheronization had no significant impact on the physical properties of the 20 
% IBU pellets, which was consistent with the findings from the PXRD and DSC results. 
 
4.2.6.4.  SEM photomicrographs of 20 % IBU pellets after spheronization 
 
SEM photomicrographs in Figure 51 show 20 % IBU pellets pre and post spheronization at 
different speeds and durations. These photomicrographs exhibited the examples of typical 
pellets and their shapes are also discussed study A (section 4.1). The size and morphology of 
the pellets appeared to change when different spheronization conditions were applied. With a 
spheronization speed of 1000 rpm, pellet shape remained cylindrical although the perimeter 
edges were rounded.  
However, surface topology was roughened due possibly to attrition or deformities left after 
pellets collided. Pellets became more spherical when spheronization speed was increased to 
2000 rpm. In addition, surface topology became smoother, indicating that the smoothening 
process due to longer spheronization duration. At spheronization speed at 3000 rpm, Ye% 
was too low (<3.5 %) and insufficient samples were obtained after spheronization and SEM 




















Figure 51. SEM photomicrographs of 20 % IBU pellets (A) pre spheronization, (B) post 
spheronization at 1000 rpm and 15 min, (C) 1000 rpm and 30 min, (D) 1000 rpm and 60 min, 




4.2.7. Drug release properties of IBU pellets 
 
The impact of spheronization and the associated mechanical forces applied during 
spheronization process on IBU release, pre and post spheronization, was studied by 
comparing the dissolution profiles carried out as according to FDA guidance. The difference 
factor (f1) and similarity factor (f2) were compared for the dissolution profiles of pellets pre 
and post spheronization, at the respective spheronization conditions. The difference factor 
(f1) measures of the relative error between the two curves and the similarity factor (f2) 
evaluate the similarity in the percent (%) dissolution between the curves. For curves to be 
considered similar, f1 values should be close to 0 and f2 values should be close to 100. In 
general,  f1 values up to 15 (0–15) and f2 values greater than 50 (50–100) are considered as 
an average difference of no more than 10 % at the sample time points (Shah et al., 1998) and 
equivalence of the two curves and thus, the performance of the test and reference products are 
equivalent (FDA, 1997). 
Due to low Ye% at the spheronization speed of 3000 rpm, insufficient samples were obtained 
for characterization including dissolution studies. Figure 52 shows the release profiles of IBU 
from 20 % IBU pellets before spheronization and after spheronization at 1000 rpm for 15 
min, 30 min and 60 min, and 2000 rpm for 15 min, 30 min and 60 min. Figure 53 shows the 
plot of the f1 and f2 values for the IBU release profiles at respective spheronization 
conditions, in comparison with IBU release profile before spheronization. It was observed 
that all f1 values were less than 15 and f2 values were greater than 50, thus indicating that 
release profiles of IBU pellets after spheronization were similar to that before spheronization. 
Therefore, it was elucidated that there was no observable impact on drug release from the 

















































Figure 52. IBU release from 20 % IBU pellets, before spheronization and after spheronization 




























































Figure 53. Comparison of f1 and f2 values of 20 % IBU pellets at 1000 rpm for 15, 30 and 60 






In this study, using IBU, a lower melting point drug with the possibility of acting as a 
plasticizer, its impact on physicochemical properties of pellets in melt spheronization was 
evaluated. The concentrations of IBU did not have a significant impact on hardness and 
brittleness of the extrudates as D50 and span values of both 20 % and 30 % IBU formulations 
were rather similar, showing no statistical difference.  However, the span of 30 % IBU was 
narrower than that of 20 % IBU. The results revealed that spheronization speed had a 
significant impact on D50 and Ye% of both formulations as both values decreased when the 
spheronization speed increased. However, spheronization duration was less impactful when 
compared to spheronization speed. Physical stability of 30 % IBU was poor after 
spheronization and the product could not be characterized. With 20 % IBU, pellets before and 
after spheronization were both physically and chemically stable and there was no observable 






4.3. Study C. Evaluation of properties of IBU pellets containing water insoluble and soluble 
spheronization aids and the impact of different types of frictional plates 
4.3.1. Experimental design for melt spheronization process 
 
The pellet properties can be affected by many operational variables during the extrusion and 
spheronization stages. Various studies have reported on the influence of spheronization 
process conditions and excipients on physicochemical and drug release properties of the 
resultant pellets (Heng et al., 1995; Heng and Koo, 2001; Law and Deasy, 1998; Liew et al., 
2007; Sarkar et al., 2013; Sinha et al., 2007; Wan et al., 1993). However, there was a scarcity 
of information on influence of different types or grades of spheronization aid on the 
physicochemical properties of pellets manufactured by using the hot melt extrusion method 
followed by the spheronization process. The spheronization of the hot melt pellets was not 
well understood. This study was designed to evaluate the influence of MCC and HPC as 
water insoluble and soluble spheronization aids on the physicochemical and viscoelastic 
properties of melt pellets. MCC (Figure 54A) is a purified, partially depolymerized cellulose 
and practically insoluble in water. Different types of MCC contain both crystalline and 
amorphous regions and the amount of amorphous fraction in MCC was reported to be around 
30 % (Kleinebudde, 1997; Rowe et al., 1994). It was reported that MCC has multiple glass 
transition temperatures which are less than 200°C but there is no significant difference in the 
degree of crystallinity among different commercial grades of MCC (Picker and Hoag, 2002; 
Rowe et al., 1994). On the contrary, HPC (Figure 54B) is a non-ionic and water-soluble 
amorphous thermoplastic polymer that softens between 100°C and 150°C based on its 
molecular weight (Prodduturi et al., 2007). A design of experiments (DOE) approach was 
employed to illustrate the influence of formulations and spheronization conditions. Four 
factors, (a) type of spheronization aid, (b) spheronization speed, (c) spheronization duration, 
and (d) frictional plate geometries, in a full factorial experimental design, were studied. A full 
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factorial DOE (3x2x2x2=24 runs each) for formulations containing MCC and HPC with a 
fixed drug load of 10 % (w/w) was used to evaluate the effects of the various parameters on 
physicochemical properties melt pellets (Figure 55). The four independent factors and the two 
levels evaluated in this study were spheronization aids (MCC and HPC), spheronization 
speeds (1000 and 3000 rpm), spheronization durations (15 and 60 min) and geometries of 






Figure 54. Molecular structure of (A) MCC and (B) HPC. 
 
It was also important to understand the influence of the physical properties of the 
spheronization aids, such as particle size and molecular weight, on physicochemical 
properties melt pellets produced. The overview of the experimental design is shown in Figure 
55 The responses obtained included physical properties such as particle size (D50) and size 
distribution (span), effective yield percent (Ye%) and particle shape (R and AR). Drug release 
rates and solid-state properties of the pellets after spheronization were also evaluated. For the 
evaluation of the effects of particle size, three commercial grades of MCC, Avicel PH 105, 
Avicel PH 101 and Avicel PH 102, with nominal particle size of 20, 50 and 100 µm 
respectively were investigated.  Similarly, three grades of HPC, Klucel EF, GF and HF with 




Figure 55. Experimental design overview. 
 
Table 9 indicates the formulations containing either MCC or HPC of various grades. By using 
DSC, the softening/melting temperatures of HPC-EF, GF and HF were estimated to be 
around 110°C to 115°C. On the other hand, it was found that the determination of glass 
transition temperature of MCC was not a trivial task as both moisture content and degree of 
crystallinity of MCC had a major impact on Tg. In addition, the color of MCC changed when 
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(Szcześniak et al., 2008).  Tg of different grades and lots of MCC had been studied and it was 
noted that  three reproducible step transitions were 132, 159 and 184°C for dry MCC (Picker 
and Hoag, 2002). However, MCC with more than 55 % crystallinity and moisture content of 
above 2 % showed a Tg value of below 120°C (Szcześniak et al., 2008). Therefore, hot melt 
extrusion temperature was set at 130°C which is above the melting point of IBU (78˚C) but 
below the decomposition stage.  
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4.3.2. Rheological properties of hot melt extruded pellets containing MCC or HPC 
 
Viscoelastic properties of materials are related to rheology which defines the deformation and 
flow of the material (Barnes et al., 1989). Thermoplastic polymers, in general, exhibit two 
different types of solid-like behaviors, viscoelastic and elastic, and the transition from glassy 
to rubbery states reflects the change from hard brittle to viscoelastic or molten rubber-like 
state, where one type of behavior is predominant during the different transition states (Gupta 
et al., 2014). G’ is a measure of the energy stored and recovered per cycle, when different 
systems are compared at the same strain amplitude which shows how solid the material is. On 
the other hand, G” describes the viscous properties of the polymer, or how liquid the sample 
is at a particular temperature and frequency.  Figure 56 and Figure 57 display the G’ and G” 
values of the formulations containing HPC and MCC. The structural network formed in 
pellets matrix is emphasized by the behavior of G’; extremely sensitive to morphological 
state. Analyzing the graphs, it can be observed that G’ monotonically rises at all the 
frequencies increasing for both IBU-MCC and IBU-HPC based formulations. At a lower 
frequency (rad/s), IBU-GF and IBU-HF showed higher G’ and when the frequency was 
increased, G’ of all formulation seems to be comparable. Similar trend was observed for G”, 




Figure 56. Storage modulus, G’ of formulations coded IBU-102, IBU-101, IBU-105, IBU-EF, 
IBU-GF and IBU-HF at 130°C and with 5 % strain rate. 
 
 
Figure 57. Loss modulus, G” of formulations coded IBU-102, IBU-101, IBU-105, IBU-EF, 




Complex viscosity (|ƞ*|) is a frequency dependent viscosity function, which is also referred to 
as dynamic viscosity (Ferry, 1980). The complex viscosities of all samples as a function of 
frequency are summarized in Figure 58. While the IBU-HPC (IBU-EF, IBU-GF and IBU-
HF) matrices displayed a pseudo-Newtonian behavior in almost the whole range of angular 
frequency, higher complex viscosity and a more pronounced shear thinning event was also 
observed. The viscosities of the pellets were in the following trend, IBU-HF > IBU-GF > 
IBU-EF, indicating that the complex viscosity increased with an increase in molecular 
weight. On the other hand, MCC based formulations with different average median particle 
sizes (D50) showed less impact of viscosities when the angular frequency was increased. 




Figure 58. Complex viscosity, |ƞ*| of formulations, IBU-102, IBU-101, IBU-105, IBU-EF, 
IBU-GF and IBU-HF at 130°C and 5 % strain rate. 
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4.3.3. Multivariate data analysis of G’ and G” values for formulations containing MCC or 
HPC as spheronization aid 
 
Multivariate data analysis was carried out to identify the underlying factors contributing to 
rheological properties of melt pellets with MCC and HPC as spheronization aids. Considering 
the nature of the dataset, principal component analysis (PCA) was used to detect 
interrelationships between G’ and G” of melt pellets containing different spheronization aids. 
PCA is used to convert a set of variables into a smaller number of representative variables, 
called principal components (PC) and the PC for the variables are orthogonal with a common 
origin. The direction of maximum variance and the variation in the data set are explained as 
much as possible by the first principal component (PC1). Each succeeding principal 
component explained (PC2, PC3, etc.) as much of the remaining variation as possible. The 
resultant correlation loading plot for G’ and G” of melt pellets containing different 
spheronization aids are shown in Figure 59 and Figure 60, respectively. In this study, 99 % 
and 1 % for G’ and 86 % and 14 % for G” of the total variation in the dataset were explained 
by PC1 and PC2, respectively (Figure 59A and Figure 60A).  
The loadings plots in Figure 59A show that G’ of IBU-102 and IBU-101 pellets are similar 
compared to that of IBU-105 pellets. Similarly, IBU-EF pellets showed distinctly different G’ 
when compared with IBU-GF or IBU-HF pellets. These observations were also confirmed by 
Figure 59B and C where the pellets contained either MCC only or HPC only were projected 
for PCA analysis. Based on PCA analysis for G’, the dataset suggested that IBU-105 and 
IBU-EF were noticeably different from the rest and pellets containing MCC as spheronization 













Figure 59. PCA loading plots for G’ of (A) IBU-102, IBU-101, IBU-105, IBU-EF, IBU-GF 
and IBU-HF formulations, (B) IBU-102, IBU-101 and IBU-105 (contain MCC), and (C) 
IBU-EF, IBU-GF and IBU-HF (contain HPC). 
 
  
 PH102-E1 = IBU-102 
 PH102-E2 = IBU-102 
 PH101-E1 = IBU-101 
 PH101-E2 = IBU-101 
 PH105-E1 = IBU-105 
 PH105-E2 = IBU-105 
 EF-E1 = IBU-EF 
 EF-E2 = IBU-EF 
 GF-E1 = IBU-GF 
 GF-E2 = IBU-GF 
 HF-E1 = IBU-HF  
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Similar trend was observed Figure 60A where the formulations with HPC and MCC were 
noticeably different. When further dissecting the formulations into either MCC specific or 
HPC specific, comparable observations were made for G” of IBU-102 and IBU-101 and they 










Figure 60. PCA loading plots for G” of (A) IBU-102, IBU-101, IBU-105, IBU-EF, IBU-GF 
and IBU-HF formulations, (B) IBU-102, IBU-101 and IBU-105 (contain MCC), and (C) 
IBU-EF, IBU-GF and IBU-HF (contain HPC).  
 PH102-E1 = IBU-102 
 PH102-E2 = IBU-102 
 PH101-E1 = IBU-101 
 PH101-E2 = IBU-101 
 PH105-E1 = IBU-105 
 PH105-E2 = IBU-105 
 EF-E1 = IBU-EF 
 EF-E2 = IBU-EF 
 GF-E1 = IBU-GF 
 GF-E2 = IBU-GF 
 HF-E1 = IBU-HF 
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4.3.4. Characteristics of pellets and factorial analysis  
 
The influence of independent variables and the interactions on the physical characteristics of 
IBU-MCC and IBU-HPC pellets under various spheronization conditions were evaluated by a 
general factorial regression analysis using Minitab. Test parameters and responses of the 
factorial study are presented in Table 10 and Table 11. The regression analysis results showed 
that IBU-MCC formulations prepared using the respective spheronization conditions showed 
higher Ye% as compared to that of IBU-HPC formulations. When spheronization speed was 
increased from 1000 to 3000 rpm, a decrease in Ye% was obtained for both IBU-MCC and 
IBU-HPC formulations. Factorial regression analysis confirmed that spheronization speed 
had significantly affected Ye% values, for both IBU-MCC and IBU-HPC formulations (Table 
10 and Table 11).   Summary of P values of independent variables and their interactions 
related to the properties on IBU-MCC and IBU-HPC melt pellets are listed in Table 12 and 
Table 13. Spheronization duration, type of MCC and frictional plate type had minimal impact 
on the physical properties of IBU-MCC pellets. However, IBU-HPC formulations were 
impacted significantly by type of HPC and spheronization duration.  
Like Ye%, mean particle size (D50) decreased when spheronization speed increased, for all 
formulations and this indicated that the pellets were either fragmented or eroded due to high 
mechanical impact forces by the frictional plate and collisions with wall of the spheronizer 
bowl.  In addition, factorial analysis supported similar observation on the significant impact 
of spheronization speeds on IBU-MCC and IBU-HPC formulations. However, types of HPC 
and spheronization durations showed statistical impact on D50 of IBU-HPC pellets. 
On the other hand, Span of the IBU-MCC and IBU-HPC was increased when the 
spheronization speed increased indication that the particle size distribution of the pellets was 
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broadened due to mechanical force varying the resulting particle sizes.  Additionally, 
spheronization speeds showed significant impact on Span. To attain at maximum product 
Ye% with narrower Span were desirable, lower spheronization speed and duration could be 
considered with either L or P frictional plate.  
Changes in pellets shape were evaluated using R and AR shape factors. Comparable pellets 
shapes of R and AR were observed for both IBU-MCC and IBU-HPC formulations. The 
values of R and AR in Table 10 and Table 11 indicating that the shapes of the pellets were 
close to spherical as R and AR were close to 1.  Influences of MCC types, spheronization 
speeds, durations or types of frictional plate seemed to have no significant impact on IBU-
MCC pellets’ shapes. However, R and AR of IBU-HPC pellets were significantly influenced 
by spheronization speeds. Spheronization durations showed an impact on AR and whereas R 
was impacted by types of HPC and frictional plates. 
In terms of interactions between variables, IBU-MCC pellets were observed no major 
influence.  IBU-HPC pellets’ Ye% (Table 12 and Table 13) showed significant interaction 
between types of HCP, spheronization speeds, durations and frictional plate types. Likewise, 
D50 and AR of the IBU-HPC pellets were statically influenced by the interaction between 




Table 10. Physical characteristics of IBU-102, IBU-101 and IBU-105 pellets at different spheronization conditions 
No Experiment code MCC 
type 
Spheronization  
speed        duration 
Frictional 
plate type 
Ye% D50 Span R AR 
1 IBU-102-1000-15-L 102 1000 15 L 98.00 1190 0.42 1.1±0.06 1.2±0.12 
2 IBU-101-1000-15-L 101 1000 15 L 96.00 1165 0.28 1.2±0.09 1.2±0.11 
3 IBU-105-1000-15-L 105 1000 15 L 91.90 1140 0.35 1.1±0.08 1.2±0.11 
4 IBU-102-1000-15-P 102 1000 15 P 95.00 1105 0.39 1.1±0.09 1.2±0.20 
5 IBU-101-1000-15-P 101 1000 15 P 80.54 919 0.55 1.1±0.09 1.2±0.17 
6 IBU-105-1000-15-P 105 1000 15 P 88.88 1054 0.39 1.1±0.17 1.4±0.52 
7 IBU-102-1000-60-L 102 1000 60 L 96.00 1060 0.46 1.1±0.07 1.2±0.16 
8 IBU-101-1000-60-L 101 1000 60 L 88.00 1160 0.31 1.1±0.11 1.2±0.19 
9 IBU-105-1000-60-L 105 1000 60 L 90.94 1108 0.40 1.1±0.08 1.1±0.08 
10 IBU-102-1000-60-P 102 1000 60 P 94.00 1140 0.42 1.1±0.06 1.2±0.13 
11 IBU-101-1000-60-P 101 1000 60 P 85.66 930 0.46 1.1±0.08 1.1±0.16 
12 IBU-105-1000-60-P 105 1000 60 P 86.48 1110 0.39 1.1±0.10 1.3±0.27 
13 IBU-102-3000-15-L 102 3000 15 L 86.00 1120 0.52 1.1±0.07 1.1±0.15 
14 IBU-101-3000-15-L 101 3000 15 L 67.00 1070 0.44 1.1±0.02 1.1±0.12 
15 IBU-105-3000-15-L 105 3000 15 L 65.63 939 0.51 1.1±0.03 1.1±0.05 
16 IBU-102-3000-15-P 102 3000 15 P 74.00 935 0.78 1.2±0.06 1.2±0.18 
17 IBU-101-3000-15-P 101 3000 15 P 67.31 980 0.62 1.1±0.03 1.1±0.09 
18 IBU-105-3000-15-P 105 3000 15 P 64.25 528 1.04 1.2±0.05 1.3±0.14 
19 IBU-102-3000-60-L 102 3000 60 L 87.00 1080 0.52 1.1±0.02 1.1±0.10 
20 IBU-101-3000-60-L 101 3000 60 L 48.00 1024 0.50 1.1±0.02 1.1±0.07 
21 IBU-105-3000-60-L 105 3000 60 L 41.84 891 0.58 1.1±0.03 1.2±0.08 
22 IBU-102-3000-60-P 102 3000 60 P 55.00 867 0.65 1.1±0.05 1.2±0.14 
23 IBU-101-3000-60-P 101 3000 60 P 36.06 883 0.64 1.1±0.03 1.1±0.06 
24 IBU-105-3000-60-P 105 3000 60 P 48.26 860 0.61 1.2±0.05 1.1±0.08 
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Table 11. Physical characteristics of IBU-EF, IBU-GF and IBU-HF pellets at different spheronization conditions 
No Experiment code HPC 
type 
Spheronization  
speed        duration 
Frictional 
plate type 
Ye% D50 Span R AR 
1 IBU-EF-1000-15-L EF 1000 15 L 96.00 920 0.41 1.1±0.06 1.2±0.11 
2 IBU-GF-1000-15-L GF 1000 15 L 93.50 1140 0.42 1.3±0.04 1.2±0.10 
3 IBU-HF-1000-15-L HF 1000 15 L 99.30 1182 0.32 1.3±0.04 1.3±0.26 
4 IBU-EF-1000-15-P EF 1000 15 P 93.00 920 0.41 1.1±0.05 1.2±0.16 
5 IBU-GF-1000-15-P GF 1000 15 P 97.10 1178 0.30 1.2±0.05 1.3±0.15 
6 IBU-HF-1000-15-P HF 1000 15 P 98.30 1190 0.34 1.2±0.09 1.2±0.12 
7 IBU-EF-1000-60-L EF 1000 60 L 93.00 1170 0.31 1.1±0.07 1.2±0.22 
8 IBU-GF-1000-60-L GF 1000 60 L 91.10 1050 0.48 1.3±0.08 1.1±0.10 
9 IBU-HF-1000-60-L HF 1000 60 L 97.90 1200 0.33 1.2±0.09 1.1±0.08 
10 IBU-EF-1000-60-P EF 1000 60 P 93.00 1170 0.32 1.1±0.06 1.2±0.12 
11 IBU-GF-1000-60-P GF 1000 60 P 94.30 1140 0.41 1.1±0.08 1.1±0.09 
12 IBU-HF-1000-60-P HF 1000 60 P 98.20 1190 0.34 1.2±0.08 1.1±0.08 
13 IBU-EF-3000-15-L EF 3000 15 L 45.00 976 0.79 1.1±0.03 1.1±0.10 
14 IBU-GF-3000-15-L GF 3000 15 L 42.20 1168 0.57 1.1±0.06 1.1±0.09 
15 IBU-HF-3000-15-L HF 3000 15 L 67.50 1158 0.45 1.2±0.05 1.2±0.17 
16 IBU-EF-3000-15-P EF 3000 15 P 56.00 976 0.79 1.1±0.04 1.1±0.14 
17 IBU-GF-3000-15-P GF 3000 15 P 45.90 1168 0.62 1.1±0.04 1.1±0.08 
18 IBU-HF-3000-15-P HF 3000 15 P 67.00 1158 0.45 1.1±0.04 1.1±0.08 
19 IBU-EF-3000-60-L EF 3000 60 L 17.00 685 0.74 1.1±0.02 1.1±0.08 
20 IBU-GF-3000-60-L GF 3000 60 L 15.50 880 0.65 1.1±0.03 1.1±0.06 
21 IBU-HF-3000-60-L HF 3000 60 L 41.20 980 0.59 1.1±0.03 1.1±0.06 
22 IBU-EF-3000-60-P EF 3000 60 P 22.00 682 0.79 1.1±0.21 1.1±0.23 
23 IBU-GF-3000-60-P GF 3000 60 P 15.10 730 0.49 1.1±0.02 1.1±0.07 



















































































A B  C D A*B A*C A*
D 
B*C B*D C*D A*B*C A*B*D B*C*D A*C*D 
Ye% NS S NS NS NS NS NS NS NS NS NS NS NS NS 
D50 NS S NS NS NS NS NS NS NS NS NS NS NS NS 
Span NS S NS NS NS NS NS NS NS NS NS NS NS NS 
R  NS NS NS NS NS NS NS NS NS NS NS NS NS NS 
AR NS NS NS NS NS NS NS NS NS NS NS NS NS NS 















































































A B  C D A*B A*C A*
D 
B*C B*D C*D A*B*C A*B*D B*C*D A*C*D 
Ye% S S S NS S NS NS S NS NS NS S S NS 
D50 S S S NS NS NS NS S NS NS NS NS NS NS 
Span NS S NS NS NS NS NS NS NS NS NS NS NS NS 
R  S S NS S S NS NS  NS NS NS NS NS NS NS 
AR NS S S NS NS NS NS S NS NS NS NS NS NS 
Note: S = Significant (where P < 0.05) and NS = Not Significant 
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4.3.4.1.  Influence of MCC particle size 
 
Uses of water insoluble and soluble spheronization aids were examined in this section (4.3- 
Study C) and three different grades of MCC (Avicel PH 102®, Avicel PH 101®, Avicel PH 
105®) with mean particle size of 100 µm, 50 µm and 20 µm were evaluated as water 
insoluble spheronization aids. The influence of MCC particle sizes on IBU-102, IBU-101 and 
IBU-105 pellets’ characteristics were assessed as part of the study. In wet extrusion 
spheronization application, MCC is a commonly used excipient due to its ideal physical 
properties (Chatlapalli and Rohera, 1998). Additionally, the physical properties of 
microcrystalline cellulose, such as moisture content, particle size, density, morphology and 
surface area, have been shown to play an important role in the quality of pellets (Sonaglio et 
al., 1995). Moreover, reports have been suggested that the particle size distribution of the 
excipients has direct impact on the pellet size distribution (Fielden et al., 1989; Wan et al., 
1993) as well as the size and sphericity of the pellets (O’Connor et al., 1984). The Ye% of 
IBU-102, IBU-101 and IBU-105 were compared in Figure 61. Results had been suggested 
that IBU-102 with various spheronization conditions showed higher Ye% compared to IBU-
101 and IBU-105 at the respective conditions. It could be elucidated that the coarse particle 
size of Avicel PH 102® when dispersed in IBU-102 had provided higher mechanical 
resistance to shear forces. No significant differences in Ye% was observed when the particle 
size of MCC used was smaller. In general, Ye% trend of IBU-102 > IBU-101 ~ IBU-105 was 
observed. Impact of frictional plate (L or P) on IBU-101 and IBU-105 pellets was similar. 
However, IBU-102 pellets showed the least impact on Ye% when L frictional plate was used, 
indicating better mechanical resistance was achieved when lower shear forces were applied. 
Therefore, the use of L frictional plate with coarser particle size MCC (Avicel PH 102®) 
could be considered for achieving higher Ye% as pellet shapes were also almost spherical, as 
120 
 
R and AR were around 1.1 to 1.2  (Table 10)  
 
 
Figure 61. Comparison of Ye% for IBU-102, IBU-101 and IBU-105 at different 
spheronization conditions. 
 
Changes in particle size distribution with respect to spheronization condition are shown in 
Figure 62.  Shifts in particle size distributions with smaller D50 (Table 10) were observed for 
all IBU-MCC pellets when they were spheronized at 3000 rpm. Impact of frictional plate (L 
or P) was insignificant and overlying particle size distributions of IBU-105 pellets were 
evidenced for the respective spheronization conditions. This could be explained by the 
presence of stronger interactions between the Avicel PH 105 particles in the polymer carrier 
that offered rigidity to the solid dispersion system and provided resistance to external 




























Figure 62. Comparison of IBU-102, IBU-101 and IBU-105 pellets size distribution 
spheronized at (A-1, B-1 and C-1) 1000 rpm and 15 min with L and P plates, (A-2, B-2 and 
C-2) 1000 rpm and 60 min with L and P plates, (A-3, B-3 and C-3) 3000 rpm and 15 min 





4.3.4.2.  Influence of HPC molecular weights 
 
Parallel to the study of the melt pellets with MCC as water insoluble spheronization aids, 
three different molecular weights of HPC (EF, GF and HF) were evaluated as water soluble 
spheronization aids.  IBU-HF pellets containing higher molecular weight (HF) showed higher 
Ye% (Figure 63) and it was supported by the factorial analysis data where the type of HPC 
had a significant impact (Table 13). Influence of frictional plate (L or P) on IBU-EF, IBU-GF 
and IBU-HF pellets showed to be less significant. Using of lower molecular weights HPC 
(EF and GF) lowered Ye% and this may not be desirable from the process efficiency 
perspective. Overlaying particle size distribution was also achieved for higher molecular 
weight HPC (Figure 64, C-1 to C-4). Therefore, if higher Ye% with narrower Span is desired, 
spheronization  of IBU-HF pellets at less than 3000 rpm and  60 min may be considered.  
 
 






























Figure 64. Comparison of IBU-EF, IBU-GF and IBU-HF pellets size distribution spheronized 
at (A-1, B-1 and C-1) 1000 rpm and 15 min with L and P plates, (A-2, B-2 and C-2) 1000 
rpm and 60 min with L and P plates, (A-3, B-3 and C-3) 3000 pm and 15 min with L and P 
plates, and (A-4, B-4 and C-4) 3000 rpm and 60 min with L and P plate. 
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4.3.5. Solid state properties 
4.3.5.1.  DSC studies 
 
IBU-MCC and IBU-HPC pellets at different spheronization speeds (1000 rpm and 3000 rpm) 
and spheronization durations (15 min and 60 min) were tested for their crystallinity and 
calorimetric properties using the DSC. With different frictional plates (L or P), the impact of 
imposed mechanical forces on the physicochemical properties of the drug in the pellets were 
evaluated.   
The DSC thermograms (Figure 65) showed, as an example of post spheronization DSC 
thermogram, IBU-102 pellets spheronized with L frictional plate had no observable IBU 
melting peak, suggesting that it was solubilized in the polymer matrix. Similar observations 
were made for all the other formulations; IBU-101, IBU-105, IBU-EF, IBU-GF and IBU-HF 
produced using different spheronization conditions. It can be deduced that IBU did not 





Figure 65. DSC thermograms of IBU-102 pellets spheronized with L frictional plate at (A) 
1000 rpm, 15 min, (B) 1000 rpm, 60 min, (C) 3000 rpm, 15 min, and (D) 3000 rpm, 60 min. 
 
4.3.5.2.  PXRD studies 
 
The PXRD patterns of pellets formulations containing IBU-102, IBU-101 and IBU-105 
produced using the spheronization conditions of 3000 rpm and 60 min with L or P frictional 
plates were shown in Figure 66. The PXRD profiles all showed a halo signal, indicating that 
the crystalline IBU was in the amorphous state and the spheronization process did revert it 
into the crystalline form.  
Similar observations were noted when the spheronization duration at 1000 rpm was increased 
from 15 min to 60 min. The PXRD profiles of the IBU-EF, IBU-GF and IBU-HF spheronized 
pellets also displayed comparable patterns with a halo signal for amorphous IBU. Therefore, 
it could be suggested that the spheronization process, under various conditions, did not 












Figure 66. PXRD patterns of the IBU-102, IBU-101 and IBU-105 (A) spheronized at 3000 
rpm and 60 min using L frictional plate and (B) spheronized at 3000 rpm and 60 min using P 
frictional plate. 
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4.3.5.3.  FT-IR analysis 
 
The changes of infrared absorption bands reflect the changes of molecular chemical structure 
and physical state of pharmaceutical drug compounds. Although infrared absorptions are 
sensitive to the changes of molecular structure or environment, not all changes can be easily 
be interpreted by comparing the FT-IR spectra alone.  Combined FT-IR and chemometric 
analysis, target transformation factor analysis (TTFA), was used to characterize the solid 
dispersion conditions in IBU-MCC formulations, pre spheronization. TTFA was carried out 
to compare IBU-102, IBU-101 and IBU-105 formulations using unmilled and ball milled 
MCC as target pure component. The projection of a target pure spectrum, 𝟏𝐱𝐯
𝐭𝐚𝐫 , onto the right 
singular vectors, 𝐕𝐳 𝐱 𝐯
𝐓 , was performed according to equation 14.  If the target and the 
projected pure component spectra are similar, then this implies that the component is present 
in the mixture (Malinowski, 2002). 
𝟏𝐱𝐯
𝐩𝐫𝐨𝐣
=  𝟏𝐱𝐯  
𝐭𝐚𝐫 [𝐕𝐳𝐱𝐯 
𝐓 ] +  𝐕𝐳𝐱𝐯
𝐓                                                      (14) 
 
The objective of this characterization was to elucidate the molecular dispersion of the IBU-
MCC system in comparison with the original MCC solid form (unmilled) and milled MCC 
amorphous form. Figure 67B and C are shown as examples of FT-IR spectra using IBU-102 
formulation for projecting with unmilled and milled MCC spectra. The spectra were recorded 
from 4,000 to 650 cm
−1
 at a resolution of 4 cm
−1
 over 20 scans. The FT-IR region of 1800–
900 cm
−1
 was assessed for comparison between samples. The sum of the squared errors (SSE) 
in Table 14 was derived from the difference between the reference (milled or unmilled MCC) 
and the projected spectrum of each formulation. Based on SSE data from Table 14, the 
projected spectra of IBU-102 and IBU-101 were similar to the references, indicating that the 
molecular dispersion within polymer matrix was relatively less interactive. On the other hand, 
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IBU-105 spectra showed a poorer projection to the references as SSE was relatively higher, 
which indicated that the molecular interactions of the system was more significant (Hopke, 
1989). It could be deduced that smaller particle size of MCC had contributed to stronger 
interactions with polymer in the system and this observation was also supported by the PCA 
data in shown in section 4.3.3 where rheological properties of IBU-105 were different from 
those of IBU-102 and IBU-101. 
 
 
Figure 67. (A) Stacked plot of IBU-102 FT-IR spectra at wave number region from 650 to 
4000 cm
-1
, (B) projected spectra at wave number region from 650 to 1800 cm
-1
 measured 
from resolved IBU-102 spectra with unmilled MCC, and (C) projected spectra at wave 
number region from 650 to 1800 cm
-1






















IBU-102 PH102 100 0.6825 0.6619 
IBU-101 PH101 50 0.6538 0.9372 
IBU-105 PH105 20 1.7328  1.7955 
 
 The IR spectra of the pellets after spheronization at 1000 rpm with L and P frictional plates are 
shown in Figure 69 and Figure 70 as examples for IBU-MCC and IBU-HPC formulations, 
respectively. They were overlaid with the IR spectra of the pellets before spheronization for 
comparison purposes.  
The FT-IR spectrum of pure IBU (Figure 68) has an intense and sharp infrared wave band at 
around 1706 cm
-1
 (carbonyl-stretching of isopropionic acid group) and broad wave bands at 2800 
- 3000 cm
-1
. As compared to the multiple bands at 2800 – 3000 cm-1 of pure IBU, these bands 
became broad in the spectra of all IBU-MCC / IBU-HPC pellets and CPV due to overlapping C–
H stretching vibrations from both the drug and the carrier polymer.   
The FT-IR spectra confirmed that spheronization speed at 1000 rpm had no significant impact on 
the physicochemical properties of IBU-MCC and IBU-HPC pellets, which is consistent with the 
conclusions from the PXRD and DSC results. In addition, spheronization using different 




















Figure 69. FT-IR spectra of pellets prior to spheronization, pellets spheronized at 1000 rpm 
for 15 or 60 min using L or P frictional plates, (A) – (B) IBU-102, (C) – (D) IBU-101, and 


































Figure 70. FT-IR spectra of pellets prior to spheronization, pellets spheronized at 1000 rpm 
for 15 or 60 min using L or P frictional plate, (A) – (B) IBU-102, (C) – (D) IBU-101, and (E) 






















4.3.5.4.  SEM 
 
Prior to spheronization, SEM photomicrographs of pellets containing MCC (Figure 71A, 
Figure 72A and Figure 73A) appeared as short rods, and surfaces were somewhat rougher, 
indicating the presence of dispersed MCC particles within the polymeric matrix. On the 
contrary, smoother surface pellets were observed with IBU-HPC formulations (Figure 74A, 
Figure 75A, and Figure 76A) suggesting the miscibility of HPC within the polymeric matrix. 
Sharp cut edges for the ends of the cylindrical rod-shape pellet were evident for both IBU-
MCC and IBU-HPC formulations and after spheronization, the edges became rounded. 
However, the surfaces of the pellets generally became less smooth. The rounding process for 
the pellets became more pronounced when the spheronization speed was increased. In 
comparison, the spheronization duration beyond 15 min and differences in the fractional plate 
geometry did not provide any additional contributions to the rounding of the pellets (Figure 






























Figure 71. SEM photomicrographs of IBU-102 pellets, (A) pre spheronization, (B) – (E) 
spheronized at 1000 rpm, and (F) – (I) spheronized at 3000 rpm for 15 and 60 min using L or 
P frictional plate. 
 

























Figure 72. SEM photomicrographs of IBU-101 pellets (A) pre spheronization, (B) – (E) 
spheronized at 1000 rpm, and (F) – (I) spheronized at 3000 rpm for 15 and 60 min using L or 





























Figure 73. SEM photomicrographs of IBU-105 pellets (A) pre spheronization, (B) – (E) 
spheronized at 1000 rpm, and (F) – (I) spheronized at 3000 rpm for 15 and 60 min using L or 
P frictional plate. 
 

























Figure 74. SEM photomicrographs of IBU-EF pellets (A) pre spheronization, (B) – (E) 
spheronized at 1000 rpm, and (F) – (I) spheronized at 3000 rpm for 15 and 60 min using L or 





























Figure 75. SEM photomicrographs of IBU-GF pellets (A) pre to spheronization, (B) – (E) 
spheronized at 1000 rpm, and (F) – (I) spheronized at 3000 rpm for 15 and 60 min using L or 
P frictional plate. 
 

























Figure 76. SEM photomicrographs of IBU-HF pellets (A) pre spheronization, (B) – (E) 
spheronized at 1000 rpm, and (F) – (I) spheronized at 3000 rpm for 15 and 60 min using L or 




4.3.6. Evaluation of IBU release from spheronized melt pellets 
 
 Release profiles of IBU from IBU-MCC and IBU-HPC pellets pre spheronization and post 
spheronization using different processing conditions were determined and compared.  Figure 
77 shows the release profiles of pre-spheronized IBU-102, IBU-101, IBU-105, IBU-EF, IBU-
GF and IBU-HF pellets. It was observed that the % release of IBU was consistently higher 
pellets with HPC than those with MCC. A possible explanation was insolubility of MCC 
which had created a mesh to entrap the drug and limited the effective surface area for 
dissolution.  IBU-102 pellets showed relatively slower IBU release, indicating that the effects 
of larger MCC particle sizes provided better shielding effects. Similar observation had been 
reported for pellets prepared by wet extrusion spheronization where prolonged drug release 
profile was attributed to the lack of disintegration of the MCC-based pellets (O'connor and 
Schwartz, 1985). Clearly, disintegration would have increased the effective surface area for 
drug dissolution. 
 In contrast, IBU-EF pellets showed relatively faster drug release and within 30 min, more 
than 90 % of IBU was released. This was also seen for all IBU-HPC pellet formulations.  
Subsequently, similarity (f2) and differences (f1) between post spheronized pellets were 
compared with those pre spheronized pellets.  As shown in Figure 78, both f1 and f2 values of 
IBU-MCC pellets were less than 15 and greater than 50, respectively. Similar trend was also 
obtained for IBU-HPC post spheronized pellets when they were compared with the pre 
spheronized pellets. Therefore, these results concluded that the spheronization process had no 
impact on IBU release from the pellets. 
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Figure 77. In vitro dissolution profiles of IBU for pre spheronized IBU-102, IBU-101, IBU-




























































































































Figure 78. Comparison of f1 and f2 values for IBU-PH102, IBU-PH101 and IBU-PH105 post 





In this study, the use of MCC and HPC as possible spheronization aids and its impact on 
physicochemical properties of pellets in melt spheronization was evaluated. The impact of 
frictional plate geometry was also assessed in this study. IBU-MCC pellets had relatively 
higher Ye% compared to IBU-HPC pellets. D50 and Span were negatively impacted for both 
IBU-MCC and IBU-HPC pellets. For achieving a high Ye% with a narrow size distribution 
and in the desirable D50, spheronization speed should be less than 3000 rpm. However, the 
spheronization duration beyond 15 min did not have any marked impact, as compared to 
spheronization speed. Both IBU-MCC and IBU-HPC pellets prepared were physically stable 
and IBU release profiles, both pre and post spheronization, were also comparable. There was 
no observable alteration in the physicochemical properties of the pellets post spheronization, 
when compared to pellets pre spheronization. Clearly, the spheronization process only 
induced morphological changes to the pellets without any impact on the physicochemical 
















In the first study (study A), CPV-PEG hot melt extruded pellets were developed and 
physicomechanical properties of CPV-PEG pellets were evaluated. A full factorial DOE with 
3 factors and 4 levels was applied to evaluate the influence of concentration of PEG 4000, 
spheronization speed, run duration and their effect on size, size distribution and shape of 
CPV-PEG pellets. In addition, pellets rheology properties of each formulation were evaluated 
for their viscoelastic properties after extrusion for the assessment of the impact of formulation 
and processing on the physicomechanical properties of pellets. All formulations in the study 
showed considerable viscous properties and among them, the formulation without PEG was 
noted to be the highest, indicating plasticizing effects of PEG which had lowered the hardness 
of formulation. Moreover, formulations containing 10 % and 15 % PEG also showed two 
phases in both DSC and rheology studies, suggesting supersaturation of PEG in the system 
that might had contributed to the weakened microstructure of polymer systems.  
Hardness and brittleness of CPV-PEG extrudates were evaluated to understand mechanical 
properties of the formulations pre spheronization. Hardness of the formulation without PEG 
was higher than the other formulations containing PEG and it could be elucidated that the 
hardness was negatively reduced in the presence of the processing aid. However, increasing 
PEG concentration had no significant impact on hardness. On the other hand, brittleness was 
positively affected by pellet shape (R and AR) where a higher concentration of PEG showed 
less brittleness and shape factors were closer to one.  
In terms of physical properties, narrow size distributions with the spans ranging from 0.29 to 
0.35 of fractionated pellets were obtained and this observation suggested that the use of the 
same backbone polymer could have resulted in products with similar particle size 
distributions. Additionally, D10, D50 and D90 values of all formulations were comparable and 
142 
 
within a close range. At lower spheronization speeds (< 2000 rpm), there were no significant 
changes in cumulative weight % undersize although the pellets were spheronized for different 
durations, from 15 min to 60 min, and only when spheronization speed was increased to 2000 
rpm and beyond, most of the formulations showed differences in cumulative weight % 
undersize which changed significantly, demonstrating that disc rotational speed had 
significant impact on pellet size and size distribution. The particle size and span showed little 
or no change when the concentration of PEG was increased. Therefore, it was postulated that 
spheronization speed was the primary factor contributing to pellet breakages which altered 
pellet size distribution profiles.  
Similarly, when the concentration for PEG was increased, Ye% decreased due to lower 
hardness of the extrudates. Less than 10 % effective yield was obtained for formulations 
containing PEG when they were spheronized at 2500 rpm. In terms of R and AR, changes 
from initial shape were not noticeable at lower spheronization speed and duration. However, 
it was observed that all the independent factors (concentration of PEG, spheronization speed 
and spheronization duration) had a significant effect on R and AR. When the concentration of 
PEG increased, both R and AR values decreased indicating the increased elastic properties 
allowed shape change and rounding without many breakages.  In the same way, R and AR of 
spheronized pellets decreased (closer to one) when the spheronization speed and duration 
increased.  
During the study, evolution of rounded pellets with respect to spheronization speed and 
duration was  observed and melt pellets rounding mechanism was proposed. 
Incorporation of a meltable drug, IBU as an unconventional plasticizing agent and its impact 
on physicochemical properties of pellets were evaluated as a second part of the study. 
Extrudate viscosity, in general, was found to be highly temperature dependent and it had 
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determined by rheological behavior of formulation components.  Feasibility runs were 
performed to evaluate processibility of 10, 20 and 30 % IBU in IBU-CPV powder blends. 
Extrusion temperatures from 110˚C to 150˚C were investigated for extrudability and thermal 
stability. Based on the TGA analysis, IBU was stable up to 128°C and when the 10 % IBU in 
the powder blend was extruded at 150°C, brownish colored extrudates were obtained, 
indicating that thermal degradation of IBU at the higher extrusion temperature. Investigations 
on the influence of 20 % and 30 % IBU in CPV-PEG pellet formulations were studied and the 
physicochemical properties of the pellets produced were evaluated. 
Extrudates mechanical properties such as hardness and brittleness showed no statistical 
differences for the two formulations and it could be explained due to lower molecular weight 
of IBU which had little impact on the mechanical properties. In addition, from DSC and XRD 
profiles, IBU-CPV pellets exhibited broad amorphous ‘halo peaks’ indicating solid form of 
amorphous solid dispersion. Based on pre spheronization product characterization, initial 
physical properties and shape factors of pellets were found not to be statistically different for 
both 20 % and 30 % IBU pellets formulations. The size and size distribution of pellets at a 
spheronization speed of 1000 rpm had little or no impact compared to the products when 
spheronization speed was increased to 2000 rpm or 3000 rpm. However, for both 20 % and 
30 % IBU formulations, no differences in D50 and size distribution were observed when the 
spheronization duration was varied. In addition, the span values of both formulations were 
less affected by spheronization speed and minimal impact on the span of the 30 % IBU in 
IBU-CPV pellets was observed due to the high extend of pellets sticking onto the side of the 
bowl.  
Based on the statistical analysis, good correlations between independent factors (%IBU and 
spheronization speed) and Ye% and D50 were achieved. Similarly, R and AR of spheronized 
pellets were significantly influenced by %IBU and spheronization speed. Evaluation from 
144 
 
solid state characterization of IBU-CPV pellets post spheronization indicated that 20 % IBU 
pellets were still in amorphous solid dispersion form despite the application of various 
magnitudes of mechanical shear forces imparted by the changes in the spheronization speed. 
However, pellets samples containing 30 % IBU in the formulation were physically unstable 
and could not be included for chemical and solid state characterizations. 
 Additionally, the impact of spheronization and the associated mechanical forces applied 
during spheronization process on the release IBU pre and post spheronization was studied and 
it was concluded that there was no observable impact on drug release from 20 % IBU pellets 
due to the spheronization process. 
Evaluation of properties of IBU pellets containing water insoluble (MCC) and soluble (HPC) 
spheronization aids and the impact of different types of frictional plates were investigated as 
the final part of the study. IBU-MCC pellets showed similar G’ and G” properties whereas 
viscosities of IBU-HPC pellets were observed in the following trend, IBU-HF > IBU-GF > 
IBU-EF. Multivariate data analysis was carried out to identify the underlying factors 
contributing to rheological properties of IBU-MCC and IBU-HPC melt pellets. From the 
data, it was suggested that IBU-105 and IBU-EF were noticeably different from the rest. 
Spheronization speed had significantly affected Ye% values, for both IBU-MCC and IBU-
HPC formulations as per factorial regression analysis.  Though spheronization duration, type 
of MCC and frictional plate type had minimal impact on the physical properties such as size 
and size distribution of IBU-MCC pellets, IBU-HPC formulations were impacted 
significantly by type of HPC and spheronization duration.  
Impact of frictional plates (L or P) showed insignificant difference in particle size distribution 
for both IBU-MCC and IBU-HPC pellets. However, IBU-MCC pellets demonstrated higher 
Ye% compared to IBU-HPC pellets and if higher Ye% with narrower span is desired, 
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spheronizing  of IBU-HF pellets at less than 3000 rpm and  60 min can be considered.  In 
addition, spheronization using different spheronization speeds and durations had also no 
significant impact on molecular dispersion of IBU in the polymer matrix and this was 
confirmed using FT-IR analysis.  
In summary, this study underlines the fact the formulation compositions, rheological 
properties and spheronization speed significantly influenced physicochemical properties hot 
melt extrudates. However, release of the IBU pellets in various formulations did not show 
any impact due to the mechanical shear applied. 
As described, melt spheronization as a direct rotary shaping process is a relatively new area 
with a very few reports published. In this thesis, we addressed important aspects relating to 
the formulation and process parameters for melt spheronization.  Production of melt pellets 
and properties of spherical pellets were elaborated. In addition the influences of 
spheronization conditions and the configuration of the spheronizer’s plate geometry on 
properties of melt pellets, such as shape in particular, were systematically studied. 
Compositions, formulations factors and viscoelastic properties of formulations were found to 
have significant effects on the sphericity of pellets. By investigating the pellet rounding 
process and evaluating physicochemical properties of the pellets, better insights into 
influence of the process parameters and formulation compositions on the produced pellet 
quality were expounded. Our study contributes to an enhanced understanding of the impact of 
the spheronization process under different conditions coupled with variations in the 
viscoelastic properties of formulations used. This thesis has seen the development melt 
spheronized pellets incorporating water soluble and insoluble processing aids with IBU as the 
model API. Future studies employing this melt spheronization method as direct rotary 
shaping process can be tried for other APIs as the formulation platforms with polymers and 
plasticizer of differing physicochemical properties. Potentially, a mathematical model with 
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different viscoelastic properties of APIs, polymers and processing aids may prove useful 
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